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Abstract 
Fusarium Head Blight (FHB) is a devastating disease that leads to severe 
economic losses to worldwide wheat (Triticum aestivum) and barley (Hordeum 
vulgare L.) production. During FHB disease development, the main causal fungal 
pathogen, Fusarium graminearum can infect a single spikelet and cause disease 
symptoms throughout the spike in susceptible wheat.  Moreover, F. graminearum 
produces trichothecene mycotoxins (eg., deoxynivalenol (DON), nivalenol (NIV) 
and their derivatives) that facilitate FHB disease development, and toxin 
contamination of the grain poses a significant threat to human and animal health. 
Two major types of resistance have been identified and deployed in breeding 
programs including: type I (resistance to initial infection) and type II (resistance to 
spread of the symptoms). Although worldwide efforts have focused on 
germplasm screening and QTL mapping of FHB resistance, unfortunately, 
resistance to FHB is quantitatively controlled and only partial. Thus, research 
efforts have expanded to identifying genes and deploying them in transgenic 
wheat. 
Previous gene expression analysis in the barley cultivar ‘Morex’ led to 
discovery of a UDP-glucosyltransferase gene, HvUGT13248, that was shown to 
provide DON resistance in transgenic yeast and Arabidopsis thaliana via 
conjugation of DON to DON-3-O-glucoside (D3G), a much less toxic derivative. 
To test this promising gene in wheat, we developed transgenic wheat expressing 
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HvUGT13248 and showed that these transgenic plants exhibited significant 
reduction of disease spread (type II resistance) in the spike compared with 
nontransformed controls. Expression of HvUGT13248 in transgenic wheat rapidly 
and efficiently conjugated DON to D3G. Under field conditions, FHB severity was 
variable between different transgenic lines; however, in some years the 
transgenic wheat showed significantly less severe disease phenotypes compared 
with the nontransformed controls. Moreover, HvUGT13248 is also capable of 
converting NIV to the detoxified derivative, NIV-3-O-β-D-glucoside (NIV3G). An 
enzymatic assay using HvUGT13248 purified from Escherichia coli showed that 
HvUGT13248 efficiently catalyzed NIV to NIV3G. Overexpression in yeast, 
Arabidopsis thaliana and wheat showed enhanced NIV resistance when grown 
on media containing different levels of NIV. Increased ability to convert nivalenol 
to NIV3G was observed in transgenic wheat, which also exhibits type II 
resistance to a NIV-producing F. graminearum strain.  
Transgenic wheat expressing HvUGT13248 also provides type II 
resistance to F. graminearum strains producing 3-ADON and NX-2, and 
resistance to root growth inhibition in 3,15-diANIV-containing media. Moreover, 
the HvUGT13248 transgene was introgressed into the elite wheat cultivars 
‘Rollag’ and ‘Linkert’, and greenhouse point inoculation results showed that 
HvUGT13248 improved FHB resistance in elite backgrounds. HvUGT13248 
overexpression in transgenic barley also enhanced DON resistance observed in 
a root assay. In conclusion, HvUGT13248 is a highly effective FHB resistant 
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gene that can detoxify a wide spectrum of trichothecene chemotypes. Thus, the 
mechanism of resistance is by rapidly detoxifying trichothecenes to their 
glucoside forms. 
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Chapter 1. Literature review 
  
Fusarium Head Blight  
Fusarium head blight (FHB; scab), caused primarily by Fusarium 
graminearum, is a disastrous disease of wheat (Triticum aestivum L.) and barley 
(Hordeum vulgare L.) that leads to dramatic reduction of grain yield and quality, 
resulting in billions of dollars of economic losses since the 1990s (Desjardins, 
1996; Goswami and Kistler, 2004; Windels, 2000). Epidemic outbreaks of FHB 
have been frequent in most wheat and barley growing regions worldwide, 
including North America, Europe, Asia and South America, indicating that FHB is 
a global threat (Goswami and Kistler, 2004). During infection, F. graminearum 
produces trichothecene mycotoxins, such as deoxynivalenol (DON), nivalenol 
(NIV) and their acetylated derivatives, that act as virulence factors and 
contaminate the grain, threatening human and animal health (Pestka, 2010; Bin-
Umer et al., 2011). Therefore, food and drug administration authorities of several 
countries and organizations, including the United States, China and the 
European Union, have established regulations on trichothecenes present in 
cereal products (United States Food and Drug Administration, 2010; GB 2761-
2011; EFSA CONTAM Panel, 2013). Thus, controlling FHB disease and reducing 
trichothecene contamination in cereal grains are top goals for agricultural 
researchers. 
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FHB disease development 
F. graminearum invades wheat and barley spikes and causes FHB 
through complex pathways. As a hemibiotrophic fungal pathogen, F. 
graminearum exhibits two distinct phases during FHB development in wheat and 
barley spikes: a biotrophic growth stage during initial infection followed by a 
necrotrophic stage (Brown et al., 2010). 
The early biotrophic invasion process is usually subcuticular and 
intercellular, and thus visually symptomless on the spikes (Leonard and Bushnell, 
2003; Jansen et al., 2005; Brown et al., 2010; Boenisch et al., 2011). When 
individual floral cavities open during anthesis, airborne F. graminearum spores 
can infect through extruded anthers or natural openings between the lemma and 
palea, and also land on spikelets and enter the florets through the stomata 
(Pritsch et al., 2000; Wanjiru et al., 2002; Leonard and Bushnell 2003; 
Lewandowski et al., 2006; Boenisch et al., 2011). Fusarium spp. may also take 
an active route for entry by directly penetrating the epidermal cuticle and cell wall 
with short infection hyphae (Wanjiru et al., 2002), facilitated by a large set of 
hydrolyzing enzymes degrading the cuticle layer (Kang and Buchenauer, 2000; 
Bushnell et al., 2003). After penetrating the cuticle, Fusarium spp. hyphae grow 
subcuticularly on the glumes, paleas and lemmas for about two days (Kang and 
Buchenauer, 2000; Pritsch et al., 2000; Jansen et al., 2005). During this stage, 
numerous cell wall-degrading enzymes are secreted by Fusarium spp. to 
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facilitate intercellular expansion (Kang and Buchenauer, 2000; Blanchette, 1991; 
Aro et al., 2005).  
After penetration of plant cell walls, Fusarium hyphae have access to the 
cell apoplast, leading to a necrotrophic intracellularly expansion phase, and 
eventually to cell death, resulting in visible water soaked and bleached tissues. 
At this stage, in susceptible plants the mycelium penetrates the rachis nodes of 
infected spikelets and colonize the vasculature (Brown et al., 2010), preventing 
the movement of water and nutrients, resulting in premature bleaching and 
shriveled grain phenotypes (Xu and Nicholson, 2009). From there, the hyphae 
pass through the rachis and spread both upward and downward to adjacent 
spikelets, and eventually colonize the majority of the spike (Brown et al., 2010; 
Miller et al., 2004; Jansen et al., 2005). However, in most barley cultivars and 
resistant wheat cultivars, the spread of disease is restricted at the rachis nodes 
of the initially infected spikelet (Jansen et al., 2005; Boenisch et al., 2011). 
During the necrotrophic stage, F. graminearum produces trichothecene 
mycotoxins (e.g., deoxynivalenol or DON) that facilitate disease development. 
The biosynthesis of trichothecenes is induced around 48 hours after infection in 
wheat and barley (Lysøe et al., 2011). Genetic studies have shown that 
trichothecenes act as virulence factors during FHB development. Disruption of 
the TRI5 gene, which encodes trichodiene synthase, the first enzyme in the 
trichothecene biosynthetic pathway, results in the lack of trichothecene 
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production and reduced virulence of F. graminearum on wheat and barley 
(Proctor et al., 1995; Jansen et al., 2005; Boddu et al., 2007). In susceptible 
wheat genotypes, F. graminearum strains carrying loss-of-function tri5 mutations 
exhibit infection only at the initial infection sites, but do not cause FHB symptom 
spread, indicating that trichothecene accumulation is important for disease 
spread within a spike (Bai et al., 2002).  
 
Trichothecene mycotoxins 
Trichothecenes are a diverse family of mycotoxins produced by a complex 
of Fusarium ssp. (Starkey et al., 2007; Alexander et al., 2011). They are non-
volatile, low molecular weight, sesquiterpene epoxides sharing the same 
molecular skeleton, and only vary at a few positions (Fig. 1.1). They are usually 
classified as Type A, B, C and D, with type A and type B trichothecenes being 
the most common and greatest concern in wheat and barley growing regions 
(Alexander et al., 2011). Type A and B trichothecenes only differ at C-8 position 
where Type B trichothecenes (e.g., deoxynivalenol (DON) and nivalenol (NIV)) 
have a keto group at C-8, while Type A trichothecenes (e.g., NX-2 and NX-3) 
have a different group, for example, a hydroxyl group, an ester, or no substitution 
at C-8 (McCormick et al., 2011).  
DON is the most prevalent chemotype found in North America and 
  5 
Europe, while comparable levels of DON and NIV were discovered in Asia and 
South America (O’Donnell et al., 2004; van der Lee et al., 2015). NIV-producing 
F. graminearum and F. asiaticum have also been identified in southern Louisiana 
(Gale et al., 2011). In addition, recent reports also identified new toxins, NX-2 
and NX-3 (Varga et al., 2015). Noteworthy, strains producing DON, NIV and their 
acetylated derivatives can all be found in the same region (van der Lee et al., 
2015), and shifts in chemotype frequency occur and may take place rapidly 
(Ward et al., 2008).   
The trichothecene skeleton is heat and chemically stable, and are not 
degraded during storage and food processing of cereal grains (Eriksen 2003) or 
autoclaving (Wannemacher et al., 2000). Therefore, after an FHB outbreak 
trichothecenes are detected in food and feed products in the market, like bread 
(Kostelanska et al., 2011) and beer (Kostelanska et al., 2009). Trichothecenes 
are also stable at neutral and acidic pH (Ueno 1987) and thus, they are intact in 
the stomach in the livestock or humans after ingestion (Eriksen 2003). 
Trichothecenes trigger severe toxic effects on animals both acutely and 
chronically. Such toxic effects include growth retardation, immunological 
responses, feed refusal and vomiting (therefore, DON is also called “vomitoxin”), 
while high doses of trichothecenes trigger serious responses, including death 
(Ueno 1983).  
At the molecular and cellular level, the toxicity of trichothecenes to 
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eukaryotic cells is primarily caused by the inhibition of protein synthesis via 
preventing peptide bond formation at the 60S ribosomal subunit (McLaughlin et 
al., 1977). Either because of translational arrest or unknown direct actions, DON 
also causes inhibition of DNA and RNA synthesis, mitochondrial dysfunction, 
disruption of cell membrane integrity and programmed cell death (Wojciechowski 
et al., 1995; Miller and Ewen, 1997; Bushnell et al., 2004; Desmond et al., 2008; 
Arunachalam and Doohan, 2013). Although trichothecenes are highly similar in 
structure, different species and cell types exhibit various sensitivity levels to 
different trichothecenes (Wakulinski, 1989; Shimada and Otani, 1990; Desjardins 
et al., 2007). For example, compared to DON, NIV was reported to have higher 
toxicity in mammalian cell lines (Eriksen et al., 2004; Pestka et al., 2005; 
Severino et al., 2006); however, the phytotoxic effects of NIV is significantly lower 
than DON when tested on Arabidopsis leaves (Desjardins et al., 2007).  
 
FHB resistance and QTL mapping 
Wheat and barley cultivars exhibit different levels of resistance to FHB, yet 
complete immunity to the disease has not been not identified in any existing 
genotypes. FHB resistance is often classified as type I (resistance to initial 
infection) and type II (resistance to disease spread within a spike) resistance 
(Mesterházy, 1995). Interestingly, most barley cultivars show natural resistance 
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to disease spread in the spike (Bushnell et al., 2003). There are three other types 
of FHB resistance which are not as frequently discussed including: type III 
(resistance to kernel infection), type IV (yield tolerance), and type V (resistance 
to mycotoxin accumulation) (Mesterházy, 1995). 
To identify genetic regions in wheat and barley genomes that provide FHB 
resistance, continuous efforts have been focused on QTL mapping studies. FHB 
resistant QTL have been identified in almost all chromosomes of wheat and 
barley genomes, except for chromosome 7D in wheat (Buerstmayr et al., 2009). 
The Chinese wheat cultivar ‘Sumai 3’ shows high level of type II resistance and 
has been widely used in QTL mapping studies. In these studies, the major QTL 
was identified on chromosome 3BS (Qfhs.ndsu-3BS or Fhb1; eg., Anderson et 
al., 2001; Bai et al., 1999; Buerstmayr et al., 2002; Liu et al., 2006; Waldron et 
al., 1999). A codominant marker UMN10 has been developed for Fhb1 and used 
in many breeding programs to select for the resistant allele at Fhb1 (Liu et al., 
2008). A recent study using mutation analysis, gene overexpression and RNAi 
downregulation techniques showed that the Fhb1 region contains a pore-forming 
toxin like domain (PFT) that confers FHB resistance, however, PFT does not 
contribute to DON detoxification, which conflicts with previous reports that the 
Fhb1 resistant QTL colocalizes with DON to deoxynivalenol-3-O-glucoside (D3G) 
detoxification (Lemmens et al., 2015), indicating another gene that impacts DON 
to D3G conversion may exist within the Fhb1 region (Rawat et al., 2016). ‘Sumai 
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3’ is also the source of a resistance QTL on 6BS, named Fhb2, which confers 
field resistance (Anderson et al., 2001; Basnet et al., 2012; Cuthbert et al., 2007; 
Waldron et al., 1999). Another QTL on chromosome 5A (Qfhs.ifa-5A) that 
provides type I resistance is also frequently detected in resistant wheat cultivars 
(Buerstmayr et al., 2003).  
In barley, QTL associated with FHB resistance have been identified on all 
barley chromosomes, and the major FHB resistance QTLs were found on 
chromosome 2H bin 8, 2H bin 10 and chromosome 6H Bin 7 (eg., de la Pena 
1999; Ma et al., 2000; Dahleen et al., 2003; Mesfin et al., 2003; Canci et al., 
2004). However, all major barley QTL are associated with morphological or 
agronomic traits, making it difficult to determine whether it is a pleiotropic effect 
or tight linkage of two genes, and creates hurdles when trying to utilize the QTL 
to increase FHB resistance in barley. FHB resistance and lower DON 
accumulation contributed by the 2H bin 8 QTL was consistently associated with 
late heading (de la Pena et al., 1999; Ma et al., 2000; Mesfin et al., 2003; Horsley 
et al., 2006). It is possible that the reduced disease phenotype could be a result 
of delayed flowering and therefore shortened exposure to the pathogen. Nduulu 
et al. (2007) fine mapped FHB severity and heading date at the 2H bin 8 QTL 
and found a recombinant that segregates lower FHB severity and earlier heading 
date, indicating that previously observed negative correlations between FHB 
severity and DON accumulation with heading date were likely due to close 
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linkage of two genes, rather than a pleiotropic effect. 
The 2H bin 10 region was repeatedly detected in mapping populations 
generated by crossing two row by six row parents (Mesfin et al., 2003; Horsley et 
al., 2006). This region harbors the Vrs1 gene, the determinant of two row or six 
row spike morphology phenotypes. In two row barley, development of the two 
lateral florets are repressed, resulting in development of the central florets. 
Therefore, two row spikes feature a more open structure and are less favorable 
for FHB development compared to six row spikes. The QTL near chromosome 
6H bin 7 is another important FHB resistant QTL (Mesfin et al., 2003; Canci et 
al., 2004; Hori et al., 2006). However, this QTL is also tightly associated with high 
grain protein content, which is an undesirable trait for barley malting and brewing 
(Canci et al., 2004). 
 
Wheat response to F. graminearum infection and trichothecene production 
Extensive studies of the host transcriptome response to F. graminearum 
infection or DON treatment have provided an understanding of wheat-F. 
graminearum and wheat-DON interactions. Comparing resistant and susceptible 
wheat cultivars, Pritsch et al., (2000) showed that defense response genes 
encoding peroxidase, pathogenesis-related proteins (PRs) PR-1, PR-2 (β-1,3-
glucanase), PR-3 (chitinase), PR-4, and PR-5 (thaumatin-like protein) genes 
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were induced in both genotypes; however, greater and faster induction of PR-4 
and PR-5 transcript were observed in the resistant line, indicating that early 
timing of defense gene regulation is important to resistance. Kong et al., (2007) 
showed that genes involved in primary metabolism, photosynthesis, plant 
defense, transcriptional regulations and protein synthesis were induced. In 
addition, Li and Yen (2008) identified 365 genes differentially expressed between 
resistant and susceptible cultivars, and several genes in the jasmonic acid 
signaling pathway were upregulated only in the resistant line, suggesting that JA 
pathway plays an important role in FHB defense. Gottwald et al., (2012) also 
identified defense genes induced by jasmonate and ethylene signaling pathways 
between a moderately resistant and susceptible wheat cultivar after F. 
graminearum inoculation. Within the differentially expressed transcripts, genes 
encoding ABC transporters, UDP-glucosyltransferases, and protease inhibitor 
proteins were upregulated in resistant wheat cultivars. Using a pair of near-
isogenic lines (NILs) carrying either the resistant or susceptible allele of Fhb1 
QTL (Anderson et al., 2001; Liu et al., 2006), Jia et al., (2009) analyzed 
transcriptomic differences between F. graminearum and mock treatment at 48 
and 96 hours after inoculation, and found 10 of the 14 differentially expressed 
genes exhibited increased expression in the resistant genotype and encoded a 
proline-rich protein, an expansin, a NB-ARC, a putative band 7 protein, a 
Bowman-Birk trypsin inhibitor, and five unknown proteins. Of the four genes that 
exhibited decreased expression in the resistant genotype, only one could be 
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annotated as a histidine-rich Ca2+-binding protein. Recent studies using RNA-
sequencing identified glucanases, NBS-LRR genes, WRKY transcription factors 
and UDP-glycosyltransferases differentially expressed after F. graminearum 
infection in NILs with resistant and susceptible alleles of Fhb1 and Qfhs.ifa-5A 
QTL. 
Transcriptomic studies also showed that DON triggers expression of 
genes associated with detoxification, JA signaling pathway, carbohydrate 
metabolism and phenylpropanoid metabolism (Walter and Doohan, 2011). 
Foroud et al., (2012) used wild-type F. graminearum, DON non-producing tri5 
mutant F. graminearum strain, and also direct DON application, and found 
theTaLTP3 gene associated with the Qfhs.ifa-5A QTL is responsive to DON. The 
TaLTP3 gene also showed high levels of basal expression in the resistant 
genotypes. In addition, TaTLP3 was also identified in NILs carrying the resistant 
allele at the Qfhs.ifa-5A QTL (Schweiger et al., 2013). In a recent RNA-seq study 
of a wheat NIL pair carrying either susceptible or resistance alleles at Fhb1, DON 
induced expression of cytochrome P450s, glutathione-S-transferases, UGTs, an 
ABC transporter, and an O-methyltransferase were observed in Fhb1+ (Hofstad 
et al., 2016). In general, the DEGs detected in rachis and spikelet samples were 
different, suggesting that F. graminearum infection and DON treatment resulted 
in differing responses. 
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Barley response to FHB and trichothecenes 
Using the Barley1 Affymetrix GeneChip (Close et al., 2004), Boddu et al. 
(2006) identified 497 probe sets differentially expressed between F. graminearum 
and water-inoculated spikelets at one or more timepoints between 24 to 144 hai 
in the susceptible barley cultivar Morex. The differentially accumulating 
transcripts were categorized as defense response, metabolic, regulatory, 
transport, miscellaneous and unknown groups (Boddu et al., 2006). Boddu et al. 
(2007) further examined the barley response to DON by comparing differentially 
expressed transcripts after inoculation with wild-type F. graminearum and tri5 F. 
graminearum mutant strains and observed transcripts responding to pathogen-
derived trichothecene accumulation including: (1) trichothecene detoxification 
genes, for example, UDP-glucosyltransferases, ABC and MATE-transporters; 
and (2) trichothecene induced plant genes that may help FHB disease 
establishment, for example, ubiquitination and programmed cell death-related 
proteins, and some transcription factors. To more precisely define the barley 
response to DON accumulation, Gardiner et al. (2010) studied Morex spikes 
treated with DON and water, and examined gene expression over time. Within 
the 255 genes that exhibited differential expression patterns between the DON 
and water treatments, 40 genes were found that were also detected in the Boddu 
et al. (2007) study. This core set of trichothecene responsive genes were 
annotated as: defense related, metabolic functions, regulatory roles, signal 
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transductions, trichothecene detoxification, miscellaneous and unknown 
functions genes. In a recent transcriptomic analysis, Huang et al. (2016) used 
RNA-Seq after F. graminearum or mock inoculation treatments to investigate the 
NILs carrying Chevron-derived resistant alleles of barley 2H Bin 8 or 6H Bin 7 
QTL, together with the recurrent susceptible parents M69 and Lacey. 
Comparison between 2H Bin 8 NIL with M69 revealed that the resistance may 
come from an elevated basal defense and quicker response after F. 
graminearum infection. Plants carrying the resistant allele at the 6H Bin 7 NIL 
build up earlier defense response than the recurrent parental line Lacey. In this 
study, 12,366 long non-coding RNAs (lncRNAs) were also identified that might 
be regulators of transcription, of which 604 lncRNAs were FHB responsive 
(Huang et al., 2016). 
 
Transgenic approaches to increase FHB and trichothecene resistance 
With the development of plant transformation technology during the past 
two decades, researchers have devoted large efforts to engineering FHB and 
DON resistance. Strategies to improve FHB and DON resistance through genetic 
modification (GM) methods mainly belong to the following categories: (1) 
increase plant innate and acquired resistance; (2) introduce proteins or peptides 
that originated from other species; (3) host induced gene silencing; and (4) 
increase resistance to trichothecenes. 
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Plant defense and defense regulatory genes 
Plant pathologists have established a fundamental understanding of plant 
genes and regulatory networks involved in pathogen resistance. For example, 
the Arabidopsis NPR1 gene is a master switch of basal and systematic acquired 
resistance, and has been shown to regulate a transcriptional cascade of defense 
response genes and provide a broad spectrum of disease resistance (Spoel and 
Dong, 2008; Dong, 2004; Cao et al., 1998). Overexpression of Arabidopsis 
thaliana NPR1 (AtNPR1) in transgenic wheat showed a highly increased type II 
resistance (Makandar et al., 2006). Similarly, overexpression of a WRKY 
transcription factor, TaWRKY45, in transgenic wheat showed high levels of type 
II FHB resistance, comparable to Sumai 3 (Bahrini et al., 2011). 
 Pathogenesis-related (PR) genes respond to pathogen infection and play 
a role in plant defense (Hammond-Kosack and Jones, 1996). Thus, several 
efforts to develop and characterize transgenic plants expressing PR genes have 
been conducted. Mackintosh et al., (2007) generated and evaluated transgenic 
wheat overexpressing a wheat α-1-purothionin gene, a barley thaumatin-like 
protein 1 (tlp-1), or a barley β-1,3-glucanase gene. All three overexpressed 
transgenes provided moderate levels of FHB type II resistance in the 
greenhouse, and in field tests showed some levels of resistance to disease 
spread, DON accumulation and kernel damage (Mackintosh et al., 2007). Taking 
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a similar strategy, Shin et al., (2008) developed transgenic wheat lines 
expressing a barley class II chitinase and showed a significant reduction in type II 
FHB severity in greenhouse point inoculation tests. Two of the seven lines also 
showed an improved resistance against FHB in the field. 
Non-specific lipid transfer proteins (nsLTPs) are capable of binding lipids 
and changing cell membrane permeability of fungal pathogens (Sun et al., 2008). 
Zhu et al., (2012) developed transgenic wheat overexpressing a wheat nsLTP 
gene (TaLTP5) and the transgenic lines exhibits a high level of resistance to 
disease spread (Zhu et al., 2012). McLaughlin et al., (2015) also demonstrated 
that two Arabidopsis thaliana nsLTPs (AtLTP4.4 and AtLTP4.5) provided 
resistance to trichothecin (Tcin), a type B trichothecene similar to DON, when 
overexpressed in transgenic Arabidopsis thaliana and yeast. 
Transgenic wheat plants expressing a radish defensin, RsAFP2, were 
developed and examined for FHB resistance (Li et al., 2011). RsAFP2 acts on 
glucopyranosylceramides in the fungal plasma membrane and lead to changes in 
membrane potential (Terras et al., 1992; 1995; Thevissen et al., 2004). 
Transgenic lines carrying RsAFP2 showed enhanced type II resistance. One line 
also displayed significantly improved resistance in field trials (Li et al., 2011). 
 
Alien antifungal proteins and peptides 
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Immunity to FHB has not been achieved through wheat and barley 
breeding, indicating that the appropriate genes may not exist within wheat and 
barley germplasm to develop cultivars with immunity. Thus, several attempts 
have been made to introduce resistance genes from other sources. Han et al. 
(2012) transformed a bovine lactoferrin gene into wheat and tested the 
transgenics with spray inoculations in the greenhouse. The transgenic lines 
showed a significant reduction of FHB incidence. Li et al. (2008) transformed the 
wheat cv. Bobwhite with a fusion protein containing a Fusarium-specific antibody 
and an antifungal peptide from Aspergillus giganteus that inhibits the growth of a 
variety of fungal species (Nakaya et al., 1990). The transgenic plants showed a 
remarkable reduction of disease severity after F. graminearum point inoculation, 
moreover, spray inoculation showed a significant reduction of FHB incidence, 
indicating that the antibody fusion protein conferred both type I and type II 
resistance.  
 In a modified approach, a gene fusion comprised of the Fusarium spp.-
specific recombinant antibody gene CWP2, and the endochitinase gene Ech42 
from the biocontrol fungus Trichoderma atroviride was transformed into wheat 
(Cheng et al., 2015a). Expression of the fusion protein was driven by a 
lemma/palea-specific promoter Lem2 from barley. Transgenic lines 
overexpressing the fusion protein showed enhanced type I and type II resistance 
in greenhouse and field point inoculations and field natural infection conditions. 
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Also, DON concentration was reduced in both greenhouse and field assays. 
These results indicate that a pathogen-inducible and tissue-specific expression of 
a resistance gene reduced the level of FHB. 
 
Host Induced Gene Silencing (HIGS) 
HIGS is an RNA-interference (RNAi)-based method for plant disease 
control. Small RNAs are produced by double stranded interfering RNAs in 
transgenic host plants, taken up by pathogens during invasion, and inhibit 
essential genes that are targeted in the pathogen, reducing pathogen growth or 
virulence levels (Nowara et al., 2010; Koch and Kogel, 2014) 
Koch et al., (2013) first successfully used HIGS to increase resistance to 
Fusaium spp.. A double stranded interfering RNA that targets the P450 lanosterol 
C-14α-demethylase (CYP51) required for ergosterol biosynthesis and fungal 
membrane integrity was transformed into barley and Arabidopsis. Expression of 
the dsRNA in Arabidopsis and barley led to resistance to F. graminearum 
infection on detached leaves and barley caryopses. However, there is a lack of 
disease screening results either in the greenhouse or the field (Koch et al., 
2013). Similarly, Cheng et al. (2015b) reported co-expression of three RNAi 
hairpin constructs targeting chitin synthase in transgenic wheat. The transgenic 
lines showed significantly enhanced type II resistance in the greenhouse and 
disease incidence in natural field infections. 
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Trichothecene antagonizing genes 
Since trichothecenes play an important role in FHB disease development, 
several candidate trichothecene-resistant genes have been studied and used in 
genetic engineered plants to provide FHB resistance. Strategies to increase 
trichothecene resistance are focused on: (1) modifying target ribosomal proteins 
to be less sensitive to trichothecenes; (2) removing trichothecenes from 
cytoplasm to reduce intracellular toxin levels and (3) detoxifying trichothecenes 
by metabolism (Table 1.1). 
The first trichothecene-resistant ribosomal protein mutants were identified 
in Saccharomyces cerevisiae strains decades ago (Schindler, 1974; Mitterbauer 
et al., 2004). In transgenic tobacco plants, overexpressing the N-terminal 
fragment of the yeast ribosomal protein L3 (RPL3) reduced DON toxicity (Di and 
Tumer, 2005), and transformed Bobwhite wheat plants showed reduced disease 
severity and DON concentration (Di et al., 2010) in both greenhouse and field 
tests. However, the improvement of FHB resistance was just moderate. In plants, 
several mutations in RPL3 genes have also been identified that show resistance 
to trichothecenes. Mitterbauer et al., (2004) transformed tobacco plants with a 
tomato RPL3 (LeRPL3) mutant cDNA and found that the transformants could 
only tolerate DON after a pretreatment with low level of DON, but did not show 
constitutive DON resistance.  
  19 
Drug efflux transporters are another class of genes antagonizing 
trichothecene toxicity. A well-studied gene is PDR5, which encodes an ABC 
(ATP-binding cassette) transporter protein. ABC transporters translocate toxins 
across the plasma membrane using energy from ATP hydrolysis (Rogers et al., 
2001). In this manner, the toxin levels at the ribosomal targets in the cytosol is 
reduced. Mitterbauer and Adam (2002) showed that without PDR5, the growth of 
yeast was inhibited by trichothecenes. Transgenic tobacco plants expressing the 
yeast PDR5 exhibited increased resistance to the trichothecene DAS (Muhitch et 
al., 2000). A possible ABC transporter gene from wheat (TaPDR1) was identified 
as induced by F. graminearum and DON (Shang et al., 2009), but there is a lack 
of functional studies. Recently, a wheat ABCC transporter gene (ABC family C 
transporter), TaABCC3.1, was shown to contribute to DON tolerance, as 
TaABCC3.1 gene-silenced wheat by virus-induced gene silencing (VIGS) 
showed increased spikelet bleaching phenotype caused by DON application. 
However, there is a lack of functional study to explain the mechanism and the 
effect of increasingTaABCC3.1 expression in wheat is not known (Walter et al., 
2015). 
In regard to trichothecene detoxification strategies, the first hint came from 
genetic studies of trichothecene biosynthetic pathways in the causal agent 
Fusarium spp. As a self-protection mechanism, the Tri101 gene catalyzes 
acetylation of the hydroxyl group at the carbon 3 position (C3-OH) to reduce the 
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toxicity of trichothecene precursors (McCormick et al., 1999), and the hydroxyl 
group gets deacetylated at the end of the biosynthetic pathway when 
trichothecenes are transported across cell membrane to outside of the fungal 
cells. As expected, transgenic tobacco plants overexpressing the F. 
graminearumTri101 gene showed increased tolerance to trichothecenes (Muhitch 
et al., 2000). However, when wheat and barley were transformed with FsTri101, 
an ortholog from F. sporotrichioides, the transgenic plants failed to show high-
level resistance to F. graminearum in field trials (Okubara et al., 2002; 
Manoharan et al., 2006). With this strategy, the ‘detoxified’ form of DON is 3-
ADON, which is less toxic to eukaryotic ribosomes, but the oral toxicity is similar 
to DON (Wu et al., 2012). Moreover, 3-ADON could be rapidly deacetylated in 
the digestive tract of mammals (Eriksen et al., 2003), or even by 
carboxylesterases in plants (Schmeitzl et al., 2015), and be converted back to 
DON. 
Another group of DON detoxification genes encode UDP-
glucosyltransferases (UGTs). UGTs constitute a huge cluster of the 
glycosyltransferase super family, which is comprised of hundreds of homologs 
from model and non-model plant species including Arabidopsis thaliana (Li et al., 
2001), Brachypodium distachyon, wheat and barley. UGTs are key players 
maintaining metabolic homeostasis in plant cells. They transfer a glucose group 
to secondary metabolites (Jones et al., 2003) and plant hormones (Tognetti et 
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al., 2010), and they also recognize challenging signals from the environment, for 
example, trichothecenes produced by Fusarium spp. (Poppenberger et al., 
2003). The first UGT capable of detoxifying DON was identified from Arabidopsis 
thaliana and was named DON glucosyl-transferase 1 (DOGT1). DOGT1 adds a 
glucoside group to the C3-OH group of DON to form D3G, a much less toxic 
form. Overexpressing the DOGT1 gene in Arabidopsis thaliana resulted in 
increased tolerance against DON but not to NIV (Poppenberger et al., 2003). A 
side-effect of overexpressing DOGT1 is that it catalyzes glucose conjugation with 
plant hormone brassinosteroids and thus leads to a dwarfing phenotype 
(Poppenberger et al., 2005). Previous work in a barley FHB-susceptible cultivar 
Morex identified a F. graminearum and DON-inducible gene encoding a UGT, 
HvUGT13248 (Boddu et al., 2007; Gardiner et al., 2010). The gene was 
confirmed to provide DON resistance by converting DON to D3G in transformed 
yeast and Arabidopsis thaliana (Schweiger et al., 2010; Shin et al., 2012). 
Moreover, the barley FHB-susceptible cultivar Morex shows resistance to 
disease spread and can convert DON to D3G, which suggests that HvUGT13248 
could be the gene that detoxifies DON in barley (Gardiner et al., 2010). In 
Brachypodium distachyon, two DON-detoxifying UGTs were also identified 
(Schweiger et al., 2013a; Pasquet et al., 2016). Bradi5g02780 is a weaker DON 
detoxifying gene, while Bradi5g03300 is more efficient when catalyzing DON to 
D3G conversion (Schweiger et al., 2013a). A comprehensive study of 
Bradi5g03300 gene was conducted in B. distachyon using mutation analysis and 
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overexpression transgenics, confirming that Bradi5g03300 gene is an effective 
for controlling FHB and reducing DON (Pasquet et al., 2016). Another barley 
UGT gene, HvUGT-10W1, was recently reported to confer FHB resistance using 
virus-induced gene silencing techniques (Xing et al., 2016). 
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Figure 1.1. Structure of different chemotypes of trichothecenes. 
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Chapter 2: Transgenic wheat expressing a barley UDP-glucosyltransferase 
detoxifies deoxynivalenol and provides high levels of resistance to 
Fusarium graminearum 
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Overview 
Fusarium head blight (FHB), mainly caused by Fusarium graminearum, is a 
devastating disease of wheat that results in economic losses worldwide. During 
infection, F. graminearum produces trichothecene mycotoxins, including 
deoxynivalenol (DON), that increase fungal virulence and reduces grain quality. 
Transgenic wheat expressing a barley UDP-glucosyltransferase (HvUGT13248) 
were developed and evaluated for FHB resistance, DON accumulation and the 
ability to metabolize DON to the less toxic DON-3-O-glucoside (D3G). Point 
inoculation tests in the greenhouse showed that transgenic wheat carrying 
HvUGT13248 exhibited significantly higher resistance to disease spread in the 
spike (type II resistance) compared to non-transformed controls. Two transgenic 
events displayed complete suppression of disease spread in the spikes. 
Expression of HvUGT13248 in transgenic wheat rapidly and efficiently 
conjugated DON to D3G, suggesting that the enzymatic rate of DON 
detoxification translates to type II resistance. Under field conditions, FHB severity 
was variable, nonetheless, transgenic events showed significantly less severe 
disease phenotypes compared to the non-transformed controls. In addition, a 
seedling assay demonstrated that the transformed plants had a higher tolerance 
to DON-inhibited root growth than non-transformed plants. These results 
demonstrate the utility of detoxifying DON as a FHB control strategy in wheat. 
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Introduction 
Fusarium head blight (FHB; scab), primarily caused by Fusarium 
graminearum, is a disease of wheat and barley that results in dramatic losses of 
grain yield and quality (Parry et al. 1995; Goswami and Kistler 2004; Kazan et al. 
2012). During infection, F. graminearum produces trichothecene mycotoxins, 
including deoxynivalenol (DON), which facilitate disease development and 
contaminate grain (Goswami and Kistler 2004). Grain products contaminated 
with trichothecenes pose human and animal health issues when consumed 
(Pestka 2010; Bin-Umer et al. 2011). For this reason the United States Food and 
Drug Administration has set the advisory level of DON at 1 ppm (mg kg-1) in 
finished wheat products for human consumption (US Food and Drug 
Administration 2010). Similarly, the European Union has established a maximum 
tolerance level of 0.75 ppm for DON in food commodities for human consumption 
(European Commission Regulation 2006). Therefore, reducing trichothecene 
concentrations in grains is essential both for food safety and in disrupting FHB 
development.  
The two major types of FHB resistance in wheat are recognized as type I 
(resistance to initial infection) and type II (resistance to disease spread in 
infected spikes) (Mesterhazy 1995). Numerous quantitative trait loci (QTL) 
associated with type I and II resistance have been identified (e.g., Waldron et al. 
1999; Anderson et al. 2001; Buerstmayr et al. 2009). A major QTL for type II 
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resistance was identified in wheat on the short arm of chromosome 3B and 
referred to as Fhb1 (Waldron et al. 1999; Anderson et al. 2001; Liu et al. 2006). 
Intensive breeding efforts have been established that have resulted in 
incorporation of QTL into elite breeding lines; however, the level of resistance 
conferred by these QTL is insufficient to alone provide protection to FHB, and the 
mechanisms of resistance provided by these QTL are not clear (Buerstmayr et al. 
2009). Transgenic wheat events expressing host defense genes and DON 
resistant genes have been developed, but these have only resulted in modest 
reductions in disease severity (Shin et al. 2008; Mackintosh et al. 2007; Okubara 
et al. 2002; Di et al. 2010). Although a recent report on host-induced gene 
silencing of a chitin synthase gene in transgenic wheat showed high levels of 
resistance to FHB (Cheng et al. 2015), there is a need to explore additional 
genetic mechanisms that perturb the infection process, thus resulting in improved 
FHB resistance. 
Previous studies have shown that trichothecenes act as virulence factors 
during FHB disease development by contributing to disease spread in the 
infected spikes. F. graminearum strains carrying loss-of-function mutations in the 
TRI5 gene, which encodes the first enzyme in the trichothecene biosynthetic 
pathway, resulted in the lack of trichothecene production and reduced virulence 
on wheat (Proctor et al. 1995). Noteworthy, these trichothecene-deficient strains 
of F. graminearum can infect wheat but were unable to spread within the spike, 
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demonstrating that trichothecenes are not required for initial infection but that 
they do play an important role in the spread of disease symptoms in the spike 
(Desjardins et al. 1996; Proctor et al. 1997; Bai et al. 2002; Jansen et al. 2005). 
Additional studies on the infection strategy of Fusarium spp. revealed that the 
pathogen has a biotrophic growth phase for about 48 hours after spore 
germination. Subsequently, the pathogen produces trichothecenes and 
transitions to a necrotrophic strategy (Brown et al. 2010; Kazan et al. 2012; 
Lysøe et al. 2011). These findings indicate that suppression of trichothecene 
accumulation at early time points may be essential for limiting FHB development. 
Previous work by Lemmens et al. (2005) examined a population segregating for 
Fhb1 QTL and found that lines containing the resistant Fhb1 allele exhibited an 
increased ability to conjugate DON with glucose to the less toxic DON-3-O-
glucoside (D3G). These results indicated that the conjugation of DON to D3G is a 
potential resistance mechanism and the authors proposed that Fhb1 likely 
encodes for either a UDP-glucosyltransferase (UGT) or a gene that regulates 
UGT activity. Taken together, this information suggests that trichothecenes play 
a major role in pathogen virulence and the identification of appropriate genes that 
encode for UGTs for subsequent expression in transgenic plants may serve as 
an avenue to reduce DON accumulation and in turn, disease severity. 
Large gene families encode UGTs in plants (Ross et al. 2001; Caputi et al. 
2012). These genes function by glucosylating plant metabolites and can also act 
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to detoxify virulence factors produced by pathogens. An Arabidopsis UGT 
(DOGT1, or AtUGT73C5) was shown to conjugate DON at the C3-OH group with 
glucose to form D3G (Poppenberger et al. 2003). Overexpression of AtUGT73C5 
in transgenic Arabidopsis resulted in DON resistance (Poppenberger et al. 2003). 
However, these same transgenics exhibited a dwarf phenotype, likely due to the 
conjugation of brassinosteroid brassinolide to the inactive brassinolide-23-O-
glucoside (Poppenberger et al. 2005). A barley UGT, HvUGT13248, is up-
regulated by F. graminearum infection and DON application (Gardiner et al. 
2010; Boddu et al. 2007). Functional characterization of HVUGT13248 showed 
that expression in both yeast and Arabidopsis imparts DON resistance by 
converting DON to D3G (Schweiger et al. 2010; Shin et al. 2012). In contrast to 
the transgenic Arabidopsis expressing DOGT1, Arabidopsis plants expressing 
HvUGT13248 did not exhibit a dwarf phenotype and the conjugation of 
brassinosteroids was not observed (Shin et al. 2012). Moreover, Brachypodium 
distachyon possesses two UGT homologs to HvUGT13248, which also showed 
resistance to high levels of DON by formation of D3G in yeast (Schweiger et al. 
2013). These results suggest UGTs are promising genes for increased FHB 
resistance in wheat. 
The overall goals of this study were to develop transgenic wheat 
expressing HvUGT13248, and to examine whether this gene increases 
resistance to F. graminearum infection and DON. The specific objectives of this 
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study were: (1) to develop transgenic wheat constitutively expressing 
HvUGT13248; (2) to evaluate these wheat lines for resistance to FHB in the 
greenhouse and in field trials; (3) to assess these wheat lines for resistance to 
DON; and (4) to monitor the conversion of DON to D3G in planta.	
 
Results 
Generation of transgenic wheat expressing HvUGT13248 
The plasmid designated, pZP212-HvUGT13248, carrying the 
HvUGT13248 gene driven by the maize ubiquitin promoter, coupled with its first 
intron (Christensen et al. 1992) (Figure 2.1A) was used for particle bombardment 
transformation of the wheat cultivar (cv.) Bobwhite (BW), and Agrobacterium-
mediated transformation of the wheat cv. CBO37. The HvUGT13248 open 
reading frame (ORF) has a C-terminal FLAG-epitope, which enables tracking of 
the HvUGT13248 protein with FLAG-epitope antibodies. To this end, western blot 
analysis using the FLAG-epitope antibodies was conducted on the T1 progeny 
derived from the primary transgenic events. Six BW transgenic events (#8, #14, 
#15, #19, #34 and #37) and four CBO37 transgenic events (#1381, #1726, 
#1386 and #1383) accumulating detectable HvUGT13248-FLAG protein levels 
were selected and allowed to self-pollinate (Fig. 2.1C). Variation in expression 
levels of the transgene was observed across the selected events, with the non-
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transformed BW and CBO37 controls displaying no detectable signal (Fig. 2.1C). 
Co-expression of the HvUGT13248 protein with the NPTII selectable marker 
(ELISA assay, see materials and methods) was observed. Thus, the NPTII 
ELISA assay was a convenient and reliable marker for presence of the active 
HvUGT13248 transgene, and subsequent determinations of HvUGT13248 
transgene expression were based on the NPTII ELISA assay.  
A Southern blot analysis was conducted on T3 individuals from the 
selected transgenic events to determine if they originated from independent 
transformation events. Genomic DNA was digested with the XbaI restriction 
endonuclease and probed with the full-length NPTII gene. The probe did not 
hybridize to BW or CBO37 non-transformed controls, while each of the BW-
derived and the CBO37-derived transgenic events exhibited different banding 
patterns, demonstrating that the transgene was successfully integrated into these 
lines and that they originated from independent transformation events (Fig. 2.1B). 
 
Evaluation of type II resistance conferred by transgenic wheat expressing 
HvUGT13248  
To evaluate type II resistance in the transgenic wheat events, we 
performed point inoculation experiments under greenhouse conditions. For each 
screen, except for the Spring 2011 trial when there was limited seed availability, 
  32 
20 plants of each transgenic event were grown and ELISA for the NPTII protein 
was performed on each plant. Between two to 20 plants from each transgenic 
event expressed the transgene, indicating that expression was relatively stable 
over generations (Supplementary Table S2.1). Plants expressing HvUGT13248 
and in some cases the non-expressing siblings (UGT-) were screened for FHB 
resistance. The susceptible check cv. Wheaton exhibited 84.7% FHB severity on 
average across all three trials, while the resistant check cv. Sumai 3 exhibited an 
average FHB severity of 10.1%, indicating that the environment for disease 
progression was successful and discriminative. Our results show the transgenic 
events significantly reduced FHB severity compared to the non-expressing 
siblings and non-transformed Bobwhite and CBO37 controls (Fig. 2.2, Table 
S2.1). Compared to the non-transformed BW control, the reduction of disease 
severity across screening T1, T2 and T3 plants from the BW transgenic events 
was at least 74% (Table S2.1). Moreover, events #15 and #19 displayed a high 
degree of type II resistance in the greenhouse assays, with negligible fungal 
spread within the spike, an equivalent type II resistant phenotype to the Sumai 3 
control. In a similar fashion, the combined results from the FHB greenhouse tests 
of the CBO37-derived transgenic events #1381, #1726, #1386 and #1383 
displayed significant reduction in disease severity greater than 64% (Fig. 2.2, 
Table S2.1), with CBO37 showing a more susceptible FHB phenotype than BW. 
Taken together, our results revealed that expression of the HvUGT13248 in 
wheat translates to enhanced type II resistance. 
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Transgenic wheat expressing HvUGT13248 promotes DON to D3G 
conversion  
To determine if the expression of HvUGT13248 in transgenic wheat is 
catalyzing the conjugation of DON to D3G, hence contributing to the observed 
type II resistance, we monitored the rate of DON conjugation, via quantification of 
DON and D3G over time. To this end, direct DON-challenge assays on 
transgenic event #19 and the corresponding BW control were conducted. Plants 
from event #19 were challenged with DON, at a 2 µg per spikelet rate applied to 
25 spikelets (50 µg or 169 nmol in total per spike) on the main spike per 
individual. Tissues samples were taken at 1, 3, 7, 14, and 21 days after DON 
challenge. DON and D3G levels were ascertained by liquid chromatography 
coupled to tandem mass spectrometry (LC-MS/MS). The conversion of DON to 
D3G was observed in event #19 and the non-transformed BW. However, the 
conversion of DON to D3G was more rapid in event #19 relative to BW, with an 
average of 24% DON converted to D3G in event #19 within the first 24 hours 
after DON application, while there was only 2% DON conversion in BW. Between 
1 to 3 days after DON application, the conversion of DON to D3G was greater in 
the non-transformed than transgenic, likely due to the lower level of DON in the 
transgenic plants. By 21 days post challenge, residual DON levels present in the 
transgenic plants were only 26% of that in BW (Fig. 2.3A and 2.3C). In addition, 
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the D3G/DON ratio trended higher in event #19 compared to BW (Fig. 2.3B). 
These results clearly demonstrate in planta UGT activity in the transgenic 
samples leads to the enhanced conversion of DON to D3G. 
 
Evaluation of field-based resistance conferred by transgenic wheat 
expressing HvUGT13248 
Transgenic wheat expressing HvUGT13248 exhibited a high level of type II 
resistance under greenhouse conditions. To gain insight on the translation of the 
resistance phenotype to a field environment, spray-inoculated experiments in 
mist-irrigated plots were conducted over the 2012-2014 growing seasons. 
Selected BW-derived transgenic lines were represented each year, while those 
from CBO37-derived transgenic lines were only in the 2013 and 2014 trials. Data 
on the various FHB-related phenotypes were monitored including: FHB incidence 
(percentage of spikes with visually symptomatic spikelets of the 20 heads 
observed), FHB severity (percentage symptomatic spikelets of the total of all 
spikelets observed), VSK (percentage of visually scabby kernels), and DON 
concentration in harvested grain (Table 2.1). In addition, D3G concentration in 
grain from the 2013 and 2014 field trials was ascertained (Table 2.1). 
Overall, FHB incidence, severity and VSK in the Bobwhite- and CBO37-
derived transgenic lines exhibited variable responses compared to the Bobwhite 
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and CBO37 non-transformed controls, respectively. All transgenic lines exhibited 
a statistically significant reduction in FHB incidence and severity in at least one 
trial except for event #1381, and VSK for at least one trial except for events #14 
and #1381. Noteworthy, all Bobwhite-derived transgenic plants exhibited a 
statistically significant reduction in FHB severity in all three trials except for event 
#37 in 2014. Importantly, event #37 in 2012 and 2013, and event #1726 in 2013 
and 2014 exhibited similar levels of FHB severity and VSK compared to the type 
II resistant commercial varieties Rollag and Alsen that carry the Fhb1 QTL. It is 
also worth noting that most transgenic events showed significantly reduced FHB 
incidence except in 2014. Taken together, our results demonstrate that 
transgenic wheat expressing HvUGT13248 can reduce the level of FHB severity 
that is comparable to FHB resistant commercial varieties, and the FHB incidence 
and VSK can be reduced when FHB disease pressure is moderate (eg., 2013). 
Since HvUGT13248 conjugates DON to D3G, the expected outcome is a 
lower concentration of DON, a higher concentration of D3G and a higher ratio of 
D3G/DON in the transgenics compared to the non-transformed controls. All 
transgenic lines, except #19, showed a higher ratio of D3G/DON than non-
transformed controls in at least one trial; however, we observed several possible 
combinations of DON and D3G concentration in the transgenics compared to the 
non-transformed controls. Consistent with our initial prediction for just the DON 
and D3G concentrations were lines #14 and #1386 in 2013, which exhibited 
statistically significant decreases in DON concentration and significant increases 
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in D3G concentration in the transgenics compared to the non-transformed 
controls. We also observed examples of significant decreases in DON and non-
significant changes in D3G concentration (e.g., lines #8, #15 and #19 in 2013; 
lines #1726 and #1383 in 2014), examples of significant decreases in both DON 
and D3G (e.g., line #1726 in 2013), examples of non-significant changes in DON 
concentration and significant increases in D3G concentration (e.g., lines # 8, #14, 
#15 and #37 in 2014), and examples of non-significant changes in DON and D3G 
concentration (e.g., #1383 in 2013; #19 in 2014, #1381 in 2013 and 2014). These 
results show that HvUGT13248 conjugates DON to D3G in field conditions but 
that there are considerable environmental factors that play a role in the DON and 
D3G concentrations in the grain. 
The three field trials provided the opportunity to assess the protection 
HvUGT13248 offered in environments exhibiting different levels of FHB pressure 
and to assess the relationship between the ratio of DON and D3G concentration 
and disease severity. We judged the severity of each field trial based on the level 
of FHB incidence in the check lines included each year. In the low disease 
environment in 2013, the transgenics exhibited the lowest level of incidence, 
severity, and VSK. Noteworthy, in 2013 the DON concentrations of all the 
transgenics were lower than the controls, and in the Bobwhite-derived transgenic 
events, the DON and D3G combined levels were lower than those of the non-
transformed BW lines except for transgenic event #14. In the higher disease 
environment in 2012, we observed a trend towards a significant reduction in FHB 
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incidence, FHB severity and VSK but the DON concentration in the transgenics 
compared to the control was not significantly different. In the highest disease 
environment in 2014, we observed a significant decrease in FHB severity of the 
transgenics although the other disease parameters exhibited high variation. Only 
transgenic line #1726 showed consistently high levels of resistance across the 
disease environments, with lower FHB incidence, higher D3G/DON ratio, and 
statistically significantly lower FHB severity, VSK, DON, and DON and D3G 
combined than the non-transformed CBO37. Our results indicate a general trend 
for the transgenics to perform best in an environment with reduced disease 
pressure, although even under high disease pressure the transgenics can confer 
a significant reduction in FHB incidence, FHB severity and VSK, although 
considerable variability with regards to DON and D3G concentration is apparent. 
 
Transgenic wheat expressing HvUGT13248 provides resistance in roots to 
DON  
DON is known to inhibit root elongation in Arabidopsis and wheat (Masuda 
et al. 2007), so we examined the root growth of selected HvUGT13248 events on 
DON-supplemented growth medium (Fig. 2.4, Fig. S2.1 and Fig. S2.2). T4 seeds 
of homozygous lineages derived from transgenic events #8, #15 and #37 along 
with the corresponding control, BW, were germinated on MS medium for 24 
hours and subsequently transferred to MS medium supplemented with 0, 2, 5 
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and 10 ppm (mg L-1) DON. Root growth was measured once a day from three to 
seven days after germination (DAG). In control treatments (0 ppm DON), root 
growth measurements for the transgenic events were not significantly different 
from BW (Fig. 2.4). However, in plates containing DON, root growth from the 
transgenic events was significantly longer than BW (Fig. 2.4). Similar results 
were observed in the transgenic events in the CBO37 background (Fig. S2.2). 
 
Expression of HvUGT13248 in wheat does not alter morphology 
To determine if the expression of HvUGT13248 in wheat resulted in 
morphological changes compared to the controls, we measured the height of the 
transgenic wheat plants and the controls in the field trials in 2013 and 2014. Our 
results showed that the transgenics were indistinguishable, except for #1726 in 
2013, from the controls under both field environments (Fig. S2.3). 
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DISCUSSION 
Transgenic wheat expressing HvUGT13248 exhibit FHB resistance and 
does not alter morphology 
Plant UGTs have previously been demonstrated to conjugate DON to the 
less toxic metabolite D3G in both yeast (Poppenberger et al. 2003; Schweiger et 
al. 2010, 2013) and Arabidopsis (Poppenberger et al. 2003; Shin et al. 2012) 
systems. To address the potential to translate these findings from model systems 
to commodity crops, as a means to mitigate pathogenesis of Fusarium spp. we 
introduced HvUGT13248 into two wheat genetic backgrounds BW and CBO37, 
and subsequently phenotyped a set of derived transgenic events under 
laboratory, greenhouse and field-based environments. The data tabulated from 
these studies clearly show that transgenic wheat events expressing 
HvUGT13248 had significantly lower FHB severities compared to their respective 
controls, over diversified environmental conditions and across two genetic 
backgrounds (Table 2.1; Fig. 2.2; Table S2.1). The results herein reveal 
HvUGT13248 expression in wheat can lead to an equivalently high level of type II 
resistance to the type II resistant cv. Sumai 3 (Fig. 2.2; Table S2.1). Previous 
transgenic approaches to enhance FHB resistance in wheat included the 
introduction of antifungal proteins wherein reduction in disease severity was 
modest in the greenhouse, ranging from 30% to 52% (Shin et al. 2008; 
Mackintosh et al. 2007; Di et al. 2010). Importantly, HvUGT13248 not only 
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enhances the type II resistance response, but also led to significant reduction in 
FHB incidence except in 2014 when disease pressure was high, which indicates 
that HvUGT13248 may also contribute to the type I resistance response by 
detoxifying DON at an early stage of initial infection. Interestingly, trichothecene 
biosynthesis is induced during the establishment of initial infection (Boenisch and 
Schäfer, 2011) but not needed for initial infection (Bai et al., 2002). Thus, 
additional research is required to determine the role that conjugation of DON to 
D3G may play in resistance to initial infection. 
HvUGT13248 belongs to the glycosyltransferase gene superfamily, which 
includes a plethora of homologous genes in plants, including Arabidopsis 
thaliana, Brachypodium distachyon, wheat, and barley (Caputi et al. 2012; Li et 
al. 2001; Schweiger et al. 2010, 2013). The Arabidopsis DOGT1 gene is capable 
of conjugating DON to D3G and overexpression of DOGT1 in Arabidopsis 
resulted in increased tolerance against DON and 15-ADON (15-acetylated DON) 
(Poppenberger et al. 2003). However, DOGT1 also catalyzes glucoside 
conjugation with brassinosteroids, resulting in a dwarf phenotype in transgenic 
Arabidopsis plants (Poppenberger et al. 2005). Unlike DOGT1, HvUGT13248 
does not produce brasinosteroid-glucosides in Arabidopsis plants, and the 
morphology of the transgenic Arabidopsis was similar to the non-transformed 
controls (Shin et al. 2012). Consistent with the previous results in Arabidopsis, 
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our results showed that expression of HvUGT13248 in wheat, with the exception 
of #1726 in 2013, does not alter plant height (Fig. S2.3). 
 
Rapid and large amount of conjugation of DON to D3G results in type II 
resistance 
The underlying mechanism associated with the observed enhanced type II 
resistance imparted by expression of the HvUGT13248 in wheat is enzymatic 
activity leading to the increased conversion rate of DON to D3G (Fig. 2.3). 
Although DON glycosylation is a common detoxification strategy in cereal crops, 
and D3G is identified in naturally contaminated fields (Berthiller et al. 2005, 
2009), our results show that the rate and amount of conjugation, especially at the 
early stage of infection, is important for resistance. In our feeding experiment, 
BW converted DON to D3G; however, transgenic line #19 converted a larger 
portion of DON to D3G in the first 24 h. In our field tests, both non-transformed 
controls BW and CBO37 accumulated higher levels of D3G compared to 
resistant checks (Sumai 3, Rollag and Alsen), and even the susceptible check, 
Wheaton, showed the ability of DON to D3G conversion. However, in all these 
lines, the ratio of D3G/DON is much lower than all of the transgenic lines. These 
results are consistent with previous reports of transgenic yeast and Arabidopsis 
expressing HvUGT13248 that showed higher resistance to DON in the growth 
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media, and ultimately higher ratios of D3G/DON compared to the non-
transformed controls (Schweiger et al. 2010; Shin et al. 2012).  
Previous attempts to provide FHB resistance through trichothecene 
metabolism via a detoxification route were largely ineffective. The Tri101 gene 
encodes an enzyme that catalyzes the acetylation of the hydroxyl group at the 
carbon 3 position (C3-OH) of trichothecene precursors to reduce toxicity 
(McCormick et al. 1999). Transgenic tobacco plants expressing the F. 
sporotrichioides-derived Tri101 gene (FsTri101) showed increased tolerance to 
trichothecenes (Muhitch et al. 2000). However, when FsTri101 was 
overexpressed in transgenic wheat (Okubara et al. 2002), the derived 
transgenics only showed partial type II resistance after point inoculation under 
greenhouse conditions.  
D3G is considered a “masked” trichothecene (Berthiller et al. 2005), given 
that D3G is not monitored during routine assays for trichothecenes, but can be 
converted back to DON by the gut microflora of mammals (Berthiller et al. 2011). 
Thus, although D3G is less phytotoxic than DON (Poppenberger et al. 2003), the 
accumulation of D3G in grain is still considered a potential health issue. 
However, the rapid conjugation of DON to D3G during the early stages of 
infection may reduce overall fungal load, which in turn may result in reduced 
DON and D3G in grain. For example, the most resistant transgenic events, #37 
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and #1726, both accumulated lower total toxin levels (DON+D3G) in the 2013 
field trial, compared to the corresponding non-transformed controls (Table 2.1). 
In summary, our results show that transgenic wheat expressing 
HvUGT13248 is an intriguing option for further exploration with the goal to 
detoxify DON and control FHB.
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MATERIALS AND METHODS 
Plant materials 
The spring wheat cultivars Alsen, Sumai 3, Rollag, Wheaton, Bobwhite 
(BW) and CBO37 were used for the experiments. BW and CBO37 were used for 
the transformation experiments. Wheaton and CBO37 are spring wheat cultivars 
that are highly susceptible to FHB. BW is a spring wheat cultivar that exhibits 
moderate susceptibility. Alsen and Rollag are spring wheat cultivars carrying the 
Fhb1 QTL inherited from Sumai 3 and exhibit type II resistance and are 
moderately resistant. Sumai 3 is a Chinese cultivar that exhibits high levels of 
type II FHB resistance. 
 
Plant transformation vector and wheat transformation 
The 1452 bp barley UDP-glucosyltransferase (HvUGT13248) gene 
containing a carboxyl-terminal FLAG-tag sequence was cloned into the pENTER 
TM/D TOPO vector (Shin et al. 2012) and then inserted into the binary 
expression plasmid pIPKb002 (Himmelbach et al. 2007) using the Gateway LR 
recombination reaction. The Ubi1 promoter forward 5’-
GGGAAGCTTGGCCTTACTAGGCTGCAGTG-3’ and nopaline synthase (NOS) 
terminator reverse 5’-CCCGGTACCCGCGTCGAGCGATCTAGTA-3’ primers 
were used for the HvUGT13248 PCR amplification including the Ubi1 promoter 
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and NOS terminator. The 2.9 kb PCR product was digested and cloned into the 
unique HindIII and KpnI sites of the vector pZP212. The pZP212 plasmid 
contains the NPTII gene driven by the cauliflower mosaic virus 35S promoter and 
terminated by the NOS gene from Agrobacterium tumefaciens (Hajdukiewicz et 
al. 1994). The spring wheat cultivar BW was used for transformation by particle 
gun bombardment method. The transformation protocols including particle gun 
bombardment of embryos, tissue culture selection and plant regeneration were 
conducted according to the protocol described by Mackintosh and colleagues 
(2006). The CBO37-derived transgenic lines were produced using 
Agrobacterium-mediated transformation according to Cheng and colleagues 
(1997). 
 
Characterization of transgenic wheat expressing HvUGT13248 
For Southern blot analysis of transgenic wheat carrying the HvUGT13248 
gene, genomic DNA (10 µg) was digested with endonuclease XbaI, separated on 
a 1% agarose gel and transferred onto Hybond N+ membranes (Amersham 
Biosciences, Piscataway, NJ, USA). The NPTII gene probe (795 bp) was derived 
from a PCR-amplified product. The forward 5'- ATGATTGAACAAGATGGATTG-
3' and reverse 5'- TCAGAAGAACTCGTCAAG-3' primers were used for the NPTII 
gene probe PCR amplification. The probe sequence was labeled with 32P dCTP 
using the Prime-a-Gene labeling system (Promega, Madison, WI, USA), following 
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the manufacturer’s instructions. The radiolabelled NPTII gene was used as a 
probe for the hybridization and the subsequent banding patterns were visualized 
using autoradiography. 
For western blot analysis, protein was extracted by grinding leaf tissues in 
extraction buffer (2% SDS, 60mM Tris-HCl (pH 6.8), 14.4 mM β-
mercaptoethanol, 10% glycerol and 0.1% (w/v) bromophenol blue) and cell 
debris was removed by centrifugation. Total protein concentration was 
determined using Bio-Rad reagent (Bio-Rad, Hercules, CA, USA) with bovine 
serum albumin as a standard. Protein extracts (10 µg for BW transgenic lines 
and 15 µg for CBO37 lines) were separated by SDS-polyacrylamide 
electrophoresis (12% acrylamide) and transferred to PVDF transfer membrane 
(Amersham Biosciences, Piscataway, NJ, USA). A DYKDDDK tag HRP-
conjugated antibody recognizing the Flag tag sequence (Cell Signaling 
Technology, Beverly, MA, USA) was used to detect the HvUGT13248-Flag 
protein at a 1: 3000 dilution. The protein was visualized using the SuperSignal 
West Pico Chemiluminescent Substrate (Thermo Scientific, Pierce 
Biotechnology, Rockford, IL, USA). 
 
Greenhouse screening of transgenic lines against F. graminearum 
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Plants were sown into Sunshine MVP growth medium (Sun Gro 
Horticulture, Agawam, MA, USA) in 6-inch square plastic pots in a greenhouse. 
Seeds from each transgenic line were planted four seeds per pot. Non-
transformed controls (BW, CBO37, Sumai 3, and Wheaton) were also planted 
four seeds per pot. Plants were fertilized with one teaspoon of Osmocote (14-14-
14 N-P-K, Scotts Company, Marysville, OH, USA) fertilizer per pot at the 3-leaf 
stage. ELISA kits (Agdia Inc., Elkhart, IN, USA) for the NPTII antibody were used 
to identify plants expressing the transgene. At anthesis, one floret of a central 
spikelet of the main spike was inoculated with 10 µL of F. graminearum 
macroconidial suspension (105 macroconidia mL-1). Inoculated spikes were 
covered with transparent plastic bags for 3 days. FHB disease severity was 
determined as the percentage of spikelets with disease symptoms on the 
inoculated spikes at 21 days after inoculation (dai). For statistical analysis, 
student’s t-tests were used to compare each transgenic event to the parental 
non-transformed controls. All analysis was performed with Microsoft Excel 
Version 2013 (Microsoft Corporation, Redmond, WA, USA). 
 
Conversion of DON to D3G in planta 
Transgenic event #19 in the BW background and the non-transformed BW 
control, 10 µL DON (0.2 µg µL-1) was introduced, at anthesis, between the palea 
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and lemma in each of 25 florets on the main spike of each plant. In this manner 
each spike received 50 µg of DON. Three spikes of each genotype were bulk-
sampled at 1, 3, 7, 14 and 21 dai. Three biological replications were conducted 
for each time point for each genotype. The spikes for each replication were 
ground in liquid nitrogen, and metabolites were extracted in four times volume of 
extraction solvent (CH3CN/H2O/HAc: 79/20/1). DON and D3G levels were 
ascertained by liquid chromatography coupled to tandem mass spectrometry 
(LC-MS/MS) according to Vendl et al. (2009). 
 
Field screening of transgenic lines against F. graminearum 
Field tests were conducted in the summers of 2012, 2013 and 2014 at the 
University of Minnesota Agricultural Experiment Station (UMore Park) in 
Rosemount, Minnesota. Seeds for the transgenic events included in the field 
trials were obtained from ELISA-positive plants in the previous generation. Non-
transformed controls (BW, CBO37, Rollag, Wheaton, and Sumai 3) were also 
planted. Entries were arranged in a randomized complete block design with four 
replications. All the lines were spray-inoculated twice. The first inoculation was 
applied at anthesis. The second inoculation was made three days after the initial 
application for each plot. The inoculum was a composite of 30 to 39 F. 
graminearum isolates at a concentration of 100,000 macroconidia mL-1. The 
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inoculum was applied using a CO2-powered sprayer fitted with a SS8003 TeeJet 
spray nozzle with an output of 10 mL sec-1 at a working pressure of 275 kPa. 
Mist-irrigation was applied from the first inoculation through disease assessment 
to facilitate FHB development. FHB incidence and severity were assessed 
visually 19-27 dai on 20 arbitrarily selected heads per plot. FHB incidence was 
determined by the percentage of spikes with visually symptomatic spikelets of the 
20 heads observed. FHB severity was determined as the percentage 
symptomatic spikelets of the total of all spikelets observed. Approximately sixty 
heads were hand harvested from each plot at maturity, threshed and the seeds 
cleaned manually. The cleaned grain samples were then used to determine the 
percentage of visually scabby kernels (VSK, Jones and Mirocha 1999). DON 
concentrations of 2012 field trial was conducted by GC-MS (Fuentes et al. 2005). 
DON and D3G concentrations of the grain samples in the 2013 and 2014 trials 
were measured using liquid chromatography-tandem mass spectrometry (Vendl 
et al. 2009). 
In the 2013 and 2014 field trials, plant height was measured in the BW 
and CBO37 transgenics and non-transformed controls. 
 
Root growth assay 
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Surface-sterilized wheat seeds of the non-transformed BW and CBO37 
controls and transgenic events #8, #15, #37, #1381, #1726, #1386 and #1383 
expressing HvUGT13248 were plated on MS growth medium to germinate. One 
day after germination, seven seedlings of each genotype were transferred to a 
square petri dish with Murashige and Skoog medium (MS media) containing 
DON. For the BW transgenics and BW non-transformed control the seedlings 
were plated on 0, 2, 5 or 10 ppm DON, and for the CBO37 transgenics and 
CBO37 non-transformed control the seedlings were plated on 0, 2 and 5 ppm 
DON. Three replicate plates of each DON concentration were used. The plates 
were positioned vertically under white light at room temperature. Pictures were 
taken of the plates every day from three days after germination. Root growth of 
seedlings was determined by measuring the longest root of each seedling from 
the pictures using the program ImageJ (Schneider et al., 2012). 
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Table 2.1. Field screening results of transgenic wheat expressing 
HvUGT13248. 
Year Line Inc. (%) Sev. (%) VSK (%) 
DON 
(nmol g-1) 
D3G 
(nmol g-1) 
D3G/DON 
D3G+DON 
(nmol g-1) 
2012 
BW 96 ± 2 40 ± 4 26 ± 5 38 ± 5 NA NA NA 
#8 76 ± 7* 15 ± 8** 18 ± 1 55 ± 4* NA NA NA 
#14 89 ± 8 24 ± 2** 20 ± 4 40 ± 8 NA NA NA 
#15 72 ± 6** 10 ± 2*** 9 ± 1** 27 ± 5 NA NA NA 
#19 65 ± 9** 11 ± 2*** 14 ± 1* 28 ± 2 NA NA NA 
#37 56 ± 9** 7 ± 2*** 9 ± 2*** 26 ± 2* NA NA NA 
Rollag 91 ± 5 27 ± 3 16 ± 3 18 ± 3 NA NA NA 
Sumai 3 48 ± 1 4 ± 0 4 ± 1 8 ± 3 NA NA NA 
Alsen 90 ± 5 25 ± 3 16 ± 2 3 ± 7 NA NA NA 
Wheaton 98 ± 1 42 ± 7 75 ± 0 59 ± 12 NA NA NA 
2013 
BW 91 ± 4 27 ± 5 8 ± 1 26 ± 3 8 ± 1 0.30 ± 0.02 34 ± 4 
#8 74 ± 6* 11 ± 2* 5 ± 1** 12 ± 2** 15 ± 4 1.16 ± 0.23* 27 ± 6 
#14 81 ± 2* 12 ± 1* 7 ± 1 18 ± 2* 17 ± 1** 0.94 ± 0.13** 35 ± 2 
#15 68 ± 6* 9 ± 1** 3 ± 1*** 8 ± 1*** 8 ± 3 0.95 ± 0.34 16 ± 4* 
#19 63 ± 4** 11 ± 2* 5 ± 0** 11 ± 3** 7 ± 3 0.52 ± 0.14 18 ± 6 
#37 39 ± 8*** 4 ± 1** 4 ± 1** 11 ± 2** 13 ± 5 1.06 ± 0.31 24 ± 6 
CBO37 83 ± 3 17 ± 3 19 ± 1 39 ± 3 22 ± 5 0.57 ± 0.12 61 ± 6 
#1381 76 ± 7 15 ± 4 16 ± 1 30 ± 4 35 ± 7 1.13 ± 0.11* 65 ± 11 
#1726 44 ± 9** 5 ± 1** 4 ± 1*** 8 ± 1*** 6 ± 1* 0.71 ± 0.09 14 ± 2*** 
#1386 55 ± 5** 7 ± 1** 11 ± 2** 27 ± 4* 56 ± 9** 2.07 ± 0.12*** 83 ± 13 
#1383 74 ± 4 9 ± 2* 8 ± 2*** 28 ± 5 33 ± 7 1.16 ± 0.08** 61 ± 11 
Rollag 63 ± 11 7 ± 1 5 ± 1 10 ± 1 3 ± 0 0.35 ± 0.05 14 ± 0 
Sumai 3 44 ± 3 3 ± 0 2 ± 1 7 ± 2 2 ± 1 0.46 ± 0.21 10 ± 3 
Alsen 75 ± 5 11 ± 1 5 ± 1 8 ± 1 2 ± 1 0.29 ± 0.10 10 ± 1 
Wheaton 95 ± 3 34 ± 4 43 ± 1 29 ± 5 7 ± 2 0.22 ± 0.04 35 ± 7 
2014 BW 100 ± 0  64 ± 3 22 ± 2 74 ± 16 6 ± 1 0.09 ± 0.02 81 ± 17 
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#8 100 ± 0 33 ± 3*** 18 ± 2 107 ± 16 21 ± 1*** 0.22 ± 0.04* 128 ± 16 
#14 98 ± 3 42 ± 6** 21 ± 2 95 ± 14 21 ± 3** 0.23 ± 0.03** 115 ± 16 
#15 96 ± 2 37 ± 11* 21 ± 3 75 ± 12 16 ± 2** 0.22 ± 0.02** 91 ± 14 
#19 100 ± 0 47 ± 4** 24 ± 4 77 ± 10 10 ± 1 0.13 ± 0.01 87 ± 11 
#37 99 ± 1 57 ± 4 20 ± 3 64 ± 9 19 ± 2** 0.30 ± 0.02*** 83 ± 12 
CBO37 98 ± 1 34 ± 5 25 ± 3 111 ± 8 17 ± 2 0.16 ± 0.02 128 ± 9 
#1381 91 ± 3 25 ± 4 19 ± 1 84 ± 12 20 ± 3 0.23 ± 0.01** 104 ± 14 
#1726 84 ± 7 16 ± 2** 16 ± 3* 52 ± 8** 18 ± 1 0.38 ± 0.08* 70 ± 7** 
#1386 95 ± 2 32 ± 3 20 ± 1 98 ± 21 25 ± 1* 0.28 ± 0.05 123 ± 20 
#1383 81 ± 6* 13 ± 1** 8 ± 1** 57 ± 6** 16 ± 1 0.28 ± 0.03** 73 ± 7** 
Rollag 93 ± 1 23 ± 1 15 ± 2 32 ± 8 2 ± 0 0.07 ± 0.01 34 ± 8 
Sumai 3 91 ± 2 18 ± 2 9 ± 2 22 ± 4 3 ± 0 0.13 ± 0.02 25 ± 4 
Alsen 93 ± 3 29 ± 3 18 ± 4 42 ± 9 4 ± 0 0.10 ± 0.03 46 ± 9 
Wheaton 98 ± 3 72 ± 9 75 ± 0 107 ± 21 6 ± 0 0.07 ± 0.01 113 ± 21 
Events #8, #14, #15, #19 and #37 are transgenic wheat expressing HvUGT13248 in the Bobwhite 
(BW) background, and events #1381, #1726, #1386 and #1383 are expressing HvUGT13248 in 
the CBO37 background. Wheaton was the susceptible check; Alsen, Rollag and Sumai 3 were 
type II resistant checks; BW and CBO37 were the non-transformed controls. Values provided are 
the means ± standard error.  
*, ** and *** indicate significance at the 0.05, 0.01 and 0.001 levels compared with the BW or 
CBO37 non-transformed controls.  
Inc. (%): FHB incidence, the percentage of spikes with visually symptomatic spikelets of the 20 
heads observed; Sev. (%): FHB severity, the percentage of diseased spikelets of the total of the 
20 spikes observed; VSK (%): the percentage of visually scabby kernels; DON and D3G 
concentrations were shown in the unit of nmol g-1. 
NA: Not available. 
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Figure 2.1. Transformation plasmid and characterization of transgenic wheat. (A) 
The pZP212 plasmid containing the HvUGT13248 transgene (pZP212-
HvUGT13248) was used for wheat transformation. NPTII, neomycin 
phosphotransferase II gene; Ubi-1 pro., maize ubiquitin-1 promoter with the first 
intron; 35S pro., cauliflower mosaic virus 35S promoter; FLAG, FLAG-epitope tag 
for western blotting. (B) Southern blot analysis using 32P-dCTP labeled NPTII 
gene and XbaI digested genomic DNA. (C) Western blot analysis using FLAG-
epitope antibody. Events #8, #14, #15, #19, #34 and #37 were independent 
transgenic lines in the Bobwhite (BW) background and BW was the non-
transformed control; #1381, #1726, #1386 and #1383 were independent 
transgenic lines in the CBO37 background and CBO37 was the non-transformed 
control. 
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Figure 2.2. FHB greenhouse screen of transgenic wheat expressing 
HvUGT13248 at 21 days after point-inoculation. FHB severity was calculated as 
the percentage of symptomatic spikelets per spike at 21 days after inoculation. 
Wheaton was the susceptible check; Sumai 3 was the resistant check. (A) 
Events #8, #14, #15, #19, #34 and #37 are transgenic wheat expressing 
HvUGT13248 in the Bobwhite (BW) background; and (B) events #1381, #1726, 
#1386 and #1383 are transgenic wheat expressing HvUGT13248 in the CBO37 
background. 
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Figure 2.3. Conjugation of DON to D3G in transgenic wheat expressing 
HvUGT13248. (A) DON and D3G concentrations in Bobwhite (BW) and 
transgenic line #19 at each time point, from 1 to 21 days after DON application. 
(B) Fold change of molar ratio of D3G to DON concentrations in BW and 
transgenic line #19 at each time point. (C) Rate of DON converted to D3G over 
time. 
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Figure 2.4. Root growth of transgenic wheat lines (#8, #15, and #37) in the 
Bobwhite (BW) background expressing HvUGT13248 on MS medium containing 
0, 2, 5 and 10 ppm DON. Pictures of plants are shown in Fig. S2.1. 
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Supplementary Table S2.1. FHB severity of transgenic wheat expressing 
HvUGT13248 in greenhouse point-inoculation tests. 
 2012 Spring 2011 Fall 2011 Spring Ave. 
Red. Line No. Sev. Red. No. Sev. Red. No. Sev. Red. 
BW 20 65 ± 9 NA 20 52 ± 9 NA 12 39 ± 12 NA NA 
#8 20 13 ± 4*** 80% 19 20 ± 4** 61% 8 7 ± 1* 82% 74% 
#14 19 19 ± 6*** 70% 16 7 ± 1*** 86% 8 7 ± 1* 82% 80% 
#14 (UGT-)    4 51 ± 21  4 36 ± 22   
#15 20 6 ± 0*** 91% 20 6 ± 0*** 88% 7 6 ± 0* 85% 88% 
#15 (UGT-)       4 53 ± 27   
#19 16 6 ± 0*** 91% 11 6 ± 0** 87% 2 6 ± 0 85% 88% 
#19 (UGT-) 4 76 ± 24  4 67 ± 22  8 53 ± 14   
#34 7 6 ± 0*** 91% 14 16 ± 7** 68% 4 7 ± 0 83% 81% 
#37 20 6 ± 0*** 91% 20 6 ± 0*** 88% 8 18 ± 12 55% 78% 
CBO37 20 91 ± 5 NA 19 100 ± 0 NA      NA 
#1381 8 23 ± 11*** 74% 17 20 ± 5*** 80%      77% 
#1381 
(UGT-) 
1 100  3 67 ± 21      
#1726 19 26 ± 7*** 72% 20 9 ± 2*** 91%      81% 
#1386 13 18 ± 7*** 80% 20 20 ± 5*** 80%      80% 
#1383 19 28 ± 8*** 69% 13 41 ± 11*** 59%       64% 
#1383 
(UGT-) 
   6 98 ± 2      
Sumai 3 36 8 ± 3   35 13 ± 4   11 9 ± 4     
Wheaton 40 85 ± 5   34 83 ± 5   12 87 ± 7     
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No.: number of plants examined in the disease screen; Sev.: FHB severity shown as the 
percentage of symptomatic spikelets in the inoculated spikes; Red.: percent disease 
reduction rate as compared to the corresponding non-transformed controls (BW or 
CBO37); Ave. Red.: average of the FHB severity reduction of three disease screens of 
the BW transgenic lines and two screens of the CBO37 transgenic lines.  
Events #8, #14, #15, #19, #34 and #37 are BW transgenic lines, and #1381, #1383, 
#1386 and #1726 are CBO37 transgenic lines. Sumai 3 was the resistant check, and 
Wheaton was the susceptible check. Values provided are the means ± standard error. 
*, ** and *** indicate significance at the 0.05, 0.01, and 0.001 levels compared with the 
non-transgenic BW control (Student’s t test). 
UGT-, indicates the individuals that segregated for the lack of HvUGT13248 expression. 
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Supplementary Figure S2.1. Bobwhite (BW) and transgenic lines #8, #15, and 
#37 expressing HvUGT13248 grown on MS medium plates with 0 and 2 ppm 
DON at 5 days after germination (DAG). Scale bars = 4cm. 
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Supplementary Figure S2.2. Root growth of CBO37 and CBO37 transgenic 
lines #1381, #1726, #1386 and #1383 expressing HvUGT13248 on MS medium 
containing 0, 2 and 5 ppm DON.  
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Supplementary Figure S2.3. Transgenic wheat expressing HvUGT13248 does 
not dramatically alter plant height. Transgenic lines #8, #14, #15, #19 and #37 
are in the Bobwhite (BW) background, and transgenic lines #1381, #1726, #1386 
and #1383 are in the CBO37 background. 
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Chapter 3: A barley UDP-glucosyltransferase inactivates nivalenol and 
provides Fusarium Head Blight resistance in transgenic wheat 
 
 
 
This chapter was published in Journal of Experimental Botany 
Li, X., H. Michlmayr, W. Schweiger, A. Malachova, S. Shin, Y. Huang, Y. Dong, G. 
Wiesenberger, S. McCormick, M. Lemmens, P. Fruhmann, C. Hametner, F. Berthiller, G. 
Adam and G.J. Muehlbauer. 2017. A barley UDP-glucosyltransferase inactivates 
nivalenol and provides Fusarium head blight resistance in transgenic wheat. J. Exp. Bot. 
68:2187-2197. 
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Overview 
 
Fusarium Head Blight is a disease of cereal crops that causes severe yield 
losses and mycotoxin contamination of grain. The main causal pathogen, 
Fusarium graminearum, produces the trichothecene toxins deoxynivalenol or 
nivalenol as virulence factors. Nivalenol-producing isolates are most prevalent in 
Asia but co-exist with DON-producers in lower frequency in North America and 
Europe. Previous studies identified a barley UDP-glucosyltransferase, 
HvUGT13248, that efficiently detoxifies deoxynivalenol, and when expressed in 
transgenic wheat results in high levels of type II resistance against 
deoxynivalenol-producing F. graminearum. Here we show that HvUGT13248 is 
also capable of converting nivalenol into the non-toxic nivalenol-3-O-b-D-
glucoside. We describe the enzymatic preparation of a nivalenol-glucoside 
standard and its use in development of an analytical method to detect the 
nivalenol-glucoside conjugate. Recombinant E. coli expressing HvUGT13248 
glycosylates nivalenol more efficiently than deoxynivalenol. Overexpression in 
yeast, Arabidopsis thaliana and wheat leads to increased nivalenol resistance. 
Increased ability to convert nivalenol to nivalenol-glucoside was observed in 
transgenic wheat, which also exhibits type II resistance to a nivalenol-producing 
F. graminearum strain. Our results demonstrate the HvUGT13248 can act to 
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detoxify deoxynivalenol and nivalenol and provide resistance to deoxynivalenol- 
and nivalenol-producing Fusarium. 
  66 
Introduction 
Small grain cereals such as wheat and barley are commonly infected by 
ascomyceteous fungi of the genus Fusarium, causing Fusarium Head Blight 
(FHB), a plant disease which leads to severe yield losses worldwide and 
contamination with trichothecene mycotoxins (Goswami and Kistler 2004; Kazan 
et al., 2012). Trichothecenes are heat-stable sesquiterpenoid compounds 
routinely found in grain intended for food and feed use (Gottschalk et al., 2009; 
Streit et al., 2012), constituting a threat to the health of humans and livestock. 
Trichothecenes are potent inhibitors of protein biosynthesis in eukaryotic cells 
and act as virulence factors of FHB disease development (Bai et al., 2001; 
Jansen et al., 2005; McCormick et al., 2011). Inability to produce trichothecenes 
in F. graminearum results in strongly reduced disease severity and spread 
(Proctor et al., 1995; Bai et al., 2001). In turn, successful detoxification of 
deoxynivalenol is associated with resistance to disease spread within spikes 
(Lemmens et al., 2005, Li et al., 2015), which is defined as type II resistance 
(Mesterhazy 1995). 
The Fusarium species causing FHB on wheat and barley produce mainly 
type A or type B trichothecenes, with the type B trichothecenes deoxynivalenol 
(DON) and nivalenol (NIV) being the greatest concern in wheat and barley 
growing regions (Alexander et al., 2011). NIV and DON differ only by an 
additional hydroxyl group at the C4 position in NIV (McCormick et al., 2011). NIV 
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is most prevalent in harvested materials from Asia and South America, whereas 
DON occurs predominantly in North America and Europe (van der Lee et al., 
2015). Noteworthy, strains producing DON, NIV and their acetylated derivatives 
can all be found in the same region (van der Lee et al., 2015), and shifts in 
chemotype frequency occur and may take place rapidly. For example, a 
Canadian survey reported a dramatic shift from 15ADON (15-
acetyldeoxynivalenol) chemotypes to 3ADON (3-acetyldeoxynivalenol) 
chemotypes within only six years (Ward et al., 2008). Thus, developing 
germplasm that exhibits resistance to a wide range of trichothecene mycotoxins 
should provide broad spectrum resistance and reduce the chance of the 
pathogen undergoing a population shift to a different chemotype composition. 
NIV orally ingested by animals is more toxic than DON (Ryu et al., 1988). 
The European Food Safety Administration established a lower tolerated daily 
intake (TDI) of 0.7 µg kg–1 body weight for NIV, compared to 1 µg kg–1 for DON 
(EFSA CONTAM Panel, 2013). The Food Safety Commission in Japan 
established a TDI for NIV of 0.4 µg kg–1 bodyweight per day (Food Safety 
Commission of Japan, 2010). NIV is not a major problem in the USA currently, 
but NIV-producing F. graminearum strains have been discovered (Gale et al., 
2011). In contrast to DON, the United States Food and Drug Administration has 
not established advisory guidelines for NIV (United States Food and Drug 
Administration, 2010).  
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DON resistance can be achieved in plants by the enzymatic conversion of 
the toxin into the non-toxic DON-3-O-glucoside (D3G) by substrate-specific UDP-
glycosyltransferase (UGT) as first demonstrated in Arabidopsis thaliana 
(Poppenberger et al., 2003). Functional homologs of DON-inactivating UGTs in 
the agronomically-relevant Pooideae subfamily have been identified in 
Brachypodium distachyon, rice and barley (Schweiger et al., 2010; 2013; 
Pasquet et al., 2016). Among these, the highly DON- and F. graminearum-
inducible barley HvUGT13248 gene (Gardiner et al., 2010) provided DON 
resistance when expressed in A. thaliana (Shin et al., 2012), and resistance to 
DON and DON-producing F. graminearum strains in transgenic wheat (Li et al., 
2015). The kinetic properties and crystal structure of the E. coli expressed and 
affinity purified gene product of OsUGT79, a rice gene highly similar to 
HvUGT13248 have been recently described (Michlmayr et al., 2015; Wetterhorn 
et al., 2016).  
Recently, NIV-3-O-glucoside (NIV3G) has been described to occur in 
naturally Fusarium-infected barley and other cereals from Finland (Nathanail et 
al., 2015). The formation of a NIV-glucoside has been demonstrated in NIV-
treated wheat (Nakagawa et al., 2011; Yoshinari et al., 2014) and NIV3G was 
purified from such material. Glycosyltransferases with specificity to NIV therefore 
exist in different cereal species, and may play a role in defense against NIV-
producers. 
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The aim of this study was to determine whether HvUGT13248 can 
inactivate and provide resistance to NIV. We show that expression of 
HvUGT13248 in yeast and A. thaliana confers NIV resistance in both model 
systems and that NIV3G can be efficiently produced by enzymatic synthesis. 
Stable transgenic events of the susceptible wheat cultivar ‘Bobwhite’ expressing 
HvUGT13248 confer increased ability to detoxify NIV and increased type II 
resistance to NIV-producing Fusarium strains.  
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Materials and Methods 
Heterologous expression of UGT in yeast  
YZGA515 is a toxin-sensitive yeast strain in which three pleiotropic drug 
resistance genes and a trichothecene-3-O-acetyltransferase have been disrupted 
(MATa leu2Δ1 trp1Δ63 ura3-52 his3Δ200 lys2-801 ade2-101 pdr5::TRP1 
pdr10::hisG pdr15::loxP-KANR-loxP ayt1::URA3), effectively rendering the strain 
unable to grow on low trichothecene concentrations (Schweiger et al., 2010). The 
strain was transformed with the previously-reported UGT genes 
DOGT1=AtUGT73C5 (pBP868) (Poppenberger et al., 2003), HvUGT13248 
(pWS1921) (Schweiger et al., 2010) and the empty vector pYAK7 (pBP910, 
Poppenberger et al., 2003). These UGTs are under control of the strong 
constitutive pADH1 promotor and are N-terminally fused to a c-Myc epitope tag. 
Transformants were selected on synthetic complete medium lacking leucine. 
Stock solutions of 10 g L-1 of DON and NIV were prepared from crystallized 
toxins and YPD plates containing 0, 40, 80 and 120 mg L-1 of either toxin were 
prepared. Exponentially grown yeast strains were rediluted in fresh selective 
medium to OD 0.05 and 0.005 and 3 µL of suspension cultures harboring either 
of the three constructs were spotted on plates containing increasing 
concentrations of NIV and DON.  
 
Recombinant expression and purification of HvUGT13248  
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HvUGT13248 was expressed in E. coli as a fusion protein with an N-
terminal His6-tag and a maltose binding protein (nHis6-MalE-HvUGT13248). The 
cDNA was amplified from pWS1921 with the oligonucleotide primers 5´-
GATATACATATGGCTGTCCACGACG-3´ and 5´-
TATATAAAGCTTTCAGCTGGCCTGGATGTC-3´ and ligated to pCA02 (a 
derivative of the pET31b-based pKLD116 (Rocco et al., 2008) containing the 
pET21d multiple cloning site) using NdeI and HindIII (restrictions sites on primers 
underlined). nHis6-MalE-HvUGT13248 was expressed with E. coli SHuffle® T7 
Express lysY (New England Biolabs, Frankfurt am Main, Germany). 
Protein expression and purification by immobilized metal ion 
chromatography (IMAC) on Ni2+-charged HisTrap Crude FF columns, 5 mL (GE 
Healthcare, Chalfont St Giles, UK) were performed as recently described for 
OsUGT79 (Michlmayr et al., 2015). After IMAC, the buffer was changed to 50 
mM potassium phosphate pH 7 + 50 mM NaCl + 10% glycerol by gel filtration on 
Sephadex G25 (GE Healthcare). One-step purified protein was stored in this 
buffer at −80 °C. Protein concentrations were determined with the Bio-Rad 
(Hercules, CA) protein assay based on the dye-binding method of Bradford. 
Enzyme assays were performed in 100 mM Tris, pH 7 at 37 °C, 2 min 
reaction time. For kinetic analyses, substrate concentrations ranged from 0.2-8 
mM (NIV) and 0.3-25 mM (DON). The assays were stopped by transferring 20 μL 
of sample to 180 μL methanol. After centrifugation (20,000 x g, 5 min) to remove 
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precipitated protein, the samples were further diluted in H2O to an expected 
concentration range of 1 mg L−1. The concentrations of NIV/NIV3G and 
DON/D3G were determined by liquid chromatography coupled with tandem mass 
spectrometry (LC-MS/MS, see below). Data regression (Michaelis Menten 
equation) was performed with SigmaPlot 11.0 (Systat Software, San Jose, CA, 
USA). Enzyme activity is reported in μmol min−1 mg−1) which refers to the 
formation of NIV3G or D3G per mg of protein. 
 
Synthesis and purification of a NIV-3-O-β-D-glucoside standard 
NIV3G was produced with OsUGT79 (Michlmayr et al., 2015) in a 44 mL 
batch containing 1.5 mM NIV, 2.6 mM UDP-glucose, 0.7 mg mL-1 nHis6-MalE-
OsUGT79. The reaction was carried out in 100 mM Tris/Cl pH 7 at 25°C for 24 h. 
Purification of NIV3G was carried out using an 1100 series preparative high 
performance liquid chromatography (HPLC) system equipped with an automatic 
fraction collector and a multiple wavelength detector (MWD) (all Agilent 
Technologies, Waldbronn, Germany). A Gemini NX column (150 × 21.2 mm, 5 
μm, Phenomenex, Aschaffenburg, Germany) and gradient elution (eluent A: 
water, eluent B: methanol) was used for the separation of NIV3G from residual 
glucose and other impurities. The initial condition of 10% B was maintained for 2 
min, followed by a linear increase to 60% B within 4 min and to 100% B within 
0.1 min. Following a hold time of 1 min at 100%, the initial conditions were 
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achieved with a fast switch to 10% B and the column was equilibrated prior to the 
next injection. The flow rate was 20 mL min−1 and the injection volume was set to 
900 μL. The fractions were collected from 4 to 6 min with the maximum peak 
duration of 1.5 min using threshold working mode. The collected fractions were 
pooled, the organic phase was evaporated on a rotary evaporator at 30 °C, and 
the remaining water phase was removed by lyophilization. The NIV3G crystals 
were weighed in a glass vial on a microbalance (16 mg) and stored at −20 °C. 
 
NMR Spectroscopy of NIV-3-O-β-D-glucoside 
1H and 13C spectra were recorded on a Bruker Avance DRX-400 MHz 
spectrometer (Bruker, Germany). Data were recorded and evaluated using 
TOPSPIN 1.3 and TOPSPIN 3.2 (Bruker Topspin, Germany). All chemical shifts 
are given in ppm relative to tetramethylsilane. The calibration was done using 
residual solvent signals. Multiplicities are abbreviated as s (singlet), d (doublet), t 
(triplet), q (quartet) and b (broad signal). Deuterated methanol was purchased 
from Eurisotop (Gif sur Yvette Cedex, Paris, France). 
 
Translation assays 
To determine the in vitro toxicity of DON, NIV and NIV-3-glucoside 
commercial in vitro transcription/translation systems (TnT® T7 Coupled Wheat 
Germ Extract System and TnT® T7 Coupled Reticulocyte Lysate System 
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(Promega, Madison, WI)) were used. Transcription/translation reactions were 
performed as described in Varga et al. (2015) with one minor change being that 
reactions with rabbit reticulocyte lysate were stopped after 20 minutes (instead of 
24 minutes) reaction time. At least three independent assays using individual 
dilutions were performed for each substance. 
 
Quantitative determination using LC-MS/MS 
LC-MS/MS analysis was performed on a QTrap 4000 mass spectrometer 
(Sciex, Foster City, CA). Chromatographic separation was achieved on a Gemini 
C18 (150 x 4.6 mm, 5 µm, Phenomenex, Aschaffenburg, Germany) at 25 °C with 
a flow rate of 0.8 ml min-1. The following water-methanol gradient (eluent A: 
80:20, v:v; eluent B: 3:97, v:v; both containing 5 mM ammonium acetate) was 
used: initial conditions at 0% B were hold for 1 min, followed by a linear increase 
to 50% B within 5 min and with a jump to 100% B. After holding 100% B for 2 
min, a fast switch to the initial conditions was performed followed by column 
equilibration until 10 min. Negative electrospray ionization mode with the 
following source settings at temperature 550 °C, ion spray voltage 4 kV, curtain 
gas 30 psi (207 kPa of 99.5% nitrogen), source gas one and two both 50 psi (345 
kPa of zero grade air), and collision gas (nitrogen) set to high. For quantitation, 
two selected reaction monitoring transitions per compound were acquired with a 
dwell time of 25 ms.  The acetate adducts of the analytes (m/z 355.1 for DON, 
m/z 371.1 for NIV, m/z 517.3 for DON3G and m/z 533.1 for NIV3G) were chosen 
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as precursors and the declustering potential (DP) was -40 V for DON and NIV, -
50 V for DON3G and -60 V for NIV3G. The following product ions were chosen 
as quantifier and qualifier, respectively: for DON m/z 59.2 (collision energy (CE) 
of -40 V) and m/z 265.2 (CE -22 V), for NIV m/z 59.1 and 281.1 (both CE -38 V), 
for DON3G m/z 427.1 (CE -30 V) and m/z 59.1 (CE -85 V) and for NIV3G m/z 
263.0 (CE -30 V) and m/z 443.0 (CE – 26 V). 
 
Transgenic Arabidopsis thaliana root growth assay 
A. thaliana seeds (Shin et al., 2012) were surface sterilized in a 20% 
bleach, 0.02% Triton X-100, 0.5% sucrose solution for 10 minutes with 
continuous shaking, then washed twice using sterilized distilled water, followed 
by cold treatment in 4° C for 3 days in the dark. Sterilized seeds were plated on 
half strength MS medium (2.15 g L-1 Murashige and Skoog salt, 0.5 g L-1 MES, 
0.5% sucrose and 10 g L-1 Agar) containing varying amounts of NIV.  
The square Petri dishes were positioned vertically at room temperature 
under 16 hours light and 8 hours dark periods. Pictures of the plates were taken 
every 24 hours starting from four days after germination. The longest root of each 
seedling was measured using ImageJ Software (Schneider et al., 2012). 
 
Greenhouse disease testing of transgenic wheat expressing HvUGT13248 
with NIV-producing F. graminearum  
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 Seeds from each wheat genotype (Li et al., 2015) were planted into 
Sunshine MVP growth medium (Sun Gro Horticulture, Agawam, MA, USA) in 6-
inch square plastic pots in a greenhouse. Twenty to thirty-two seeds were 
planted for each transgenic event with each pot containing four seeds. Twenty 
seeds of non-transformed controls (‘Bobwhite’, ‘Sumai 3’ and ‘Wheaton’) were 
also planted at four seeds per pot. Plants were fertilized with one teaspoon of 
Osmocote (14-14-14 N-P-K, Scotts Company, Marysville, OH) fertilizer per pot at 
the 3-leaf stage. Plants expressing the transgene were detected based on ELISA 
assays (Agdia Inc, Elkhart, IN, USA) with an NPTII antibody as described in Li et 
al., (2015). Only transgenic plants expressing NPTII were analyzed further.  
 At anthesis, one floret of a central spikelet of the main spike was 
inoculated with 10 µL of macroconidial suspension (105 macroconidia mL-1 and 
0.01% Triton X-100) of the NIV-producing F. graminearum strain 02-15 (Gale at 
al., 2011). Inoculated spikes were covered with transparent plastic bags for 3 
days. FHB disease severity was determined as the percentage of spikelets with 
disease symptoms on the inoculated spikes at 21 days after inoculation. For 
statistical analysis, student’s t-tests were used to compare each transgenic line 
to the non-transformed ‘Bobwhite’ control.  
DON, NIV and ergosterol were measured on NIV-producing F. 
graminearum inoculated wheat via gas chromatography – mass spectrometry 
(GC-MS) as described (Jiang et al. 2006; Dong et al. 2006) using whole spikes 
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sampled at 21 days after point inoculation. Nine spikes were sampled from each 
genotype of wheat tested in the 2013 fall greenhouse screen. 
 
Conversion of NIV to NIV3G in planta in transgenic wheat expressing 
HvUGT13248 
 Transgenic wheat expressing HvUGT13248, HvUGT13248-#19, and the 
non-transformed ‘Bobwhite’ control were inoculated at anthesis with 10 µL of 
aqueous NIV solution (2 µg µL-1) between the palea and lemma in the central 
four florets on the main spike of each plant. In this manner, each spike received 
80 µg of NIV. Spikes were sampled at 0, 2, 6, 12, 24, 36, 48, 72, 96 hours and 14 
days after treatment. Nine biological replications were completely randomized 
during growth and one central spike per replication was used for each time point 
for each genotype. The inoculated four florets with rachis tissue for each 
replication were ground in liquid nitrogen, and metabolites were extracted in four 
times volume of extraction solvent (50% methanol). NIV and NIV3G levels were 
ascertained by LC-MS/MS as described above.  
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Results 
HvUGT13248 provides resistance to NIV in yeast  
The glycosylation of DON by plant UGTs is well established as a major 
detoxification process and can be monitored by the increased accumulation of 
D3G in plant extracts (Shin et al., 2012; Li et al., 2015; Pasquet et al., 2016). 
Recently, NIV3G has been detected in barley and other cereal species 
(Nathanail et al., 2015), which may be due to either the activity of a UGT or 
different enzymes. Toxin sensitive baker’s yeast transformed with either the 
barley HvUGT13248 or the A. thaliana AtUGT73C5 genes produce the 
recombinant proteins as previously confirmed by western blotting using an 
antibody detecting the N-terminal c-Myc epitope tag (Schweiger et al., 2010). To 
test for resistance to DON and NIV, transformants expressing HvUGT13248 or 
AtUGT73C5 were spotted on agar medium containing increasing amounts of NIV 
or DON. While both UGTs conferred DON resistance as described before, only 
the transformants expressing HvUGT13248 grew on plates containing up to 120 
mg L-1 of NIV (Fig. 1). The results also show that NIV is less toxic for yeast than 
DON. While 40 mg L-1 of DON was completely inhibitory for the strain containing 
the empty vector, 40 mg L-1 NIV caused only a moderate reduction of growth 
compared to the control without toxin. 
 
NIV is converted to NIV-3-O-b-D-glucoside by purified HvUGT13248 
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To investigate the fate of NIV in vitro, we examined the biochemical 
properties of the HvUGT13248 enzyme towards NIV as a substrate. We 
expressed HvUGT13248 and a previously-characterized highly similar rice UGT 
OsUGT79, which also converts DON to D3G in E. coli (Michlmayr et al., 2015). 
Both enzymes were produced as fusion proteins with an N-terminal His6-tag and 
a malE domain to improve solubility. While OsUGT79 was highly expressed and 
easily purified, HvUGT13248 was only very weakly expressed and highly 
unstable, preventing further purification after the first immobilized metal ion 
chromatography (IMAC) purification step. Nevertheless, the analysis of the 
enzymatic reaction by HPLC-MS showed that both OsUGT79 and HvUGT13248 
can metabolize NIV into a substance with a mass expected for a NIV-glucoside. 
HvUGT13248 yielded a product with an identical MS/MS fragmentation pattern 
as the product of OsUGT79, demonstrating that both generate the same 
substance. 
For structural elucidation of this glucoside, we therefore employed 
OsUGT79 to synthesize the compound in preparative amounts. From 20 mg NIV 
in a first experiment, 16 mg NIV3G were purified. The NIV-glucoside from this 
first reaction was purified by preparative HPLC and subjected to NMR analysis. 
Theoretically, the glucose could be linked to any of the four hydroxy groups in 
NIV (C3-OH, C4-OH, C7-OH, C15-OH). The NMR results confirmed exclusive 
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glucosylation of NIV at the C3 position with glucopyranose linked in β-
configuration (Fig. S1).   
Both OsUGT79 and HvUGT13248 recombinant fusion proteins were 
characterized with respect to kinetic properties towards NIV and DON (Table 1). 
The kcat values for HvUGT13248 might be underestimated, due to lower purity 
after only one purification step. The results nevertheless indicate that 
HvUGT13248 has higher affinity and about 5-fold higher catalytic efficiency 
towards NIV compared to DON.  
 
NIV3G has minimal inhibitory activity at the ribosomal target  
The primary mode of action of trichothecenes is inhibition of eukaryotic 
protein synthesis. To test whether NIV3G can inhibit animal and plant ribosomes, 
we utilized coupled in vitro transcription and translation systems, where 
ribosomes either from rabbit reticulocytes or from a wheat germ extract translate 
a luciferase reporter gene. As shown in Fig. 2 and supplementary Fig. S2, both 
NIV and DON efficiently block translation in both systems. For wheat ribosomes 
the IC50 for DON was 1.6 µM, and 0.7 µM for NIV. Likewise, in rabbit 
reticulocytes the IC50 for DON and NIV were 1.4 µM and 0.8 µM, respectively. 
Thus, NIV is slightly more inhibitory for ribosomes than DON for both animal and 
plant ribosomes. NIV-glucoside showed strongly reduced inhibitory activity (Fig. 2 
and Fig. S2) in both systems, as previously described for D3G (Poppenberger et 
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al., 2003). At the highest NIV3G concentration (200 µM) used in the translation 
assays about 30% inhibition was observed in the wheat germ assay (Fig. 2). The 
IC20 for NIV and NIV3G were reached at 0.3 µM and 90 µM, respectively, in the 
wheat germ assay, corresponding to an about 300-fold reduction in translation 
inhibition. Similarly, in the rabbit reticulocyte system 600-fold more NIV3G than 
NIV is required to result in 20% translation inhibition (see Fig. S2). Results of 
molecular modeling (Pierron et al., 2016) suggest that the addition of the bulky 
glucose group should completely prevent interaction with the ribosomal binding 
site. The slight translation inhibition at extremely high NIV3G levels (200 µM or 
about 95 mg L-1) could theoretically be caused by partial hydrolysis of the 
glucoside during the assay, as previously observed for acetylated trichothecene 
(NX-2; Varga et al., 2015). We therefore analyzed samples from the end-points 
of the assay (stopped by precipitation with acetonitrile). However, no NIV was 
detectable in any of the samples (data not shown). We can therefore exclude that 
the minor residual inhibitory effect was due to hydrolytic cleavage of NIV3G. 
 
Increased NIV resistance in transgenic A. thaliana expressing HvUGT13248  
To investigate whether HvUGT13248 provides resistance to NIV in plants, 
we tested transgenic A. thaliana expressing HvUGT13248 on NIV-supplemented 
growth medium (Fig. 3 and Fig. S3). Two transgenic lines (#40 and #42) 
previously reported by Shin et al., (2012), along with a non-transformed Col-0 
control, were grown on half-strength MS medium supplemented with 0 or 100 mg 
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L-1 NIV. The results show that in the control treatment (0 mg L-1 NIV), root length 
of the transgenic lines were not significantly different from the non-transformed 
Col-0 (Fig. 3A and Fig. S3). When grown on medium containing 100 mg L-1 NIV, 
the roots of both transgenic lines were significantly longer than Col-0 (Fig. 3D 
and Fig. S3). Therefore, transgenic A. thaliana expressing HvUGT13248 show 
increased resistance to high concentrations of NIV. 
 
Transgenic wheat expressing HvUGT13248 exhibits type II resistance to 
NIV-producing F. graminearum 
To test NIV resistance in transgenic wheat expressing HvUGT13248, we 
performed point inoculation assays with a NIV-producing F. graminearum strain 
(Gale et al., 2011). Transgenic wheat carrying HvUGT13248 (independent 
transgenic lines #8, #15, #19 and #37 previously described in Li et al., 2015), 
‘Bobwhite’, ‘Sumai 3’ and ‘Wheaton’, were evaluated for type II resistance. We 
repeated this disease screen in the greenhouse three times and for each screen, 
20 to 32 plants of each transgenic event were grown. The susceptible check 
‘Wheaton’ exhibited FHB severity levels that ranged between 58.6 ± 7.3% and 
86.9 ± 5.1%; while the resistant check ‘Sumai 3’ exhibited FHB severity levels 
that ranged between 6.5 ± 0.6% to 8.0 ± 1.3%, indicating the environments for 
FHB severity screening were successful and discriminative (Fig. 4; Table S1). 
The checks also demonstrate differences in FHB severity between the trials, 
which is a frequent observation when assaying FHB severity (eg., Okubara et al., 
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2002; Li et al., 2015). The transgenic lines significantly reduced FHB severity 
compared with the non-transformed ‘Bobwhite’ control (Fig. 4 and Table S1). For 
the three greenhouse trials, transgenic line #8 showed FHB severity of 8.2 - 
20.2%, #15 showed 6.8 - 9.6% severity, #19 showed 6.7 - 15.1% severity, and 
#37 showed 6.8 - 13.2% severity. All four transgenic lines exhibited significant 
reduction of FHB severity relative to ‘Bobwhite’ ranging from 71.1 - 90.3%. Three 
of transgenic lines (#15, #19 and #37) showed FHB severity in more than one 
trial at levels similar to the resistant line Sumai 3. NIV and ergosterol contents 
were also measured on whole spikes by gas chromatograph-mass spectrometry 
(GC-MS) during the 2013 greenhouse trial (Table 2). All four transgenic lines 
accumulated significantly less NIV and ergosterol compared with ‘Bobwhite’. 
DON did not accumulate to detectable levels in the transgenic lines or ‘Sumai 3’; 
however, in ‘Bobwhite’ and ‘Wheaton’, we observed a small amount of DON 
accumulation. These results indicate that the NIV-producing strain also produces 
trace amount of DON, and when inoculated on genotypes (e.g., ‘Wheaton’ and 
‘Bobwhite’) that have less capacity to detoxify trichothecenes, a small amount of 
DON is detected. Taken together, transgenic wheat expressing HvUGT1348 
exhibited high levels of type II resistance to a NIV-producing F. graminearum 
strain and lowered NIV content. 
 
Increased NIV to NIV3G conversion in transgenic wheat 
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To determine if the enhanced type II resistance conferred by 
HvUGT13248 was indeed due to increased glycosylation, we monitored the NIV 
and NIV3G concentrations in transgenic line #19 and the Bobwhite 
nontransgenic control from 0 to 14 days after NIV application. Two central 
spikelets on the main spike of transgenic line #19 and non-transformed 
‘Bobwhite’ were inoculated with NIV at 40 µg per spikelet (80 µg or 256.41 nmol 
NIV per spike). Treated spikelets together with the connecting rachis tissue were 
collected at ten time points: 0, 2, 6, 12, 24, 36, 48, 72, and 96 hours and 14 days 
after NIV application. NIV and NIV3G concentrations were measured by LC-
MS/MS. 
NIV concentration decreased and NIV3G concentration increased in both 
transgenic and non-transformed wheat (Fig. 5; Table S2), indicating that both 
genotypes possess NIV-glycosyltransferase activity. However, the conversion 
was faster in transgenic line #19 than in ‘Bobwhite’ at early time points. Before 6 
hours after NIV injection, NIV concentrations in line #19 were significantly lower 
than ‘Bobwhite’, while NIV3G contents were significantly higher than ‘Bobwhite’. 
NIV3G concentrations continued to be significantly higher in line #19 at 12 hours 
and 24 hours after treatment. Average NIV3G/NIV ratios in the transgenic lines 
were significantly higher than in ‘Bobwhite’ during the first 24 hours after NIV 
application except for 12-hour time point. After 36 hours, the differences between 
transgenic and non-transformed lines were not significant, indicating that the 
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greatest impact of HvUGT13248 overexpression on NIV to NIV3G conversion is 
at early time points.  
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Discussion 
The HvUGT13248 gene product can metabolize different trichothecene 
toxins 
Family 1 UDP-glycosyltransferases (UGT) comprise a large family of 
genes (Caputi et al., 2012). UGTs play important roles in diverse biological 
processes (Ross et al., 2001) and UGT genes seem to evolve rapidly by 
amplification and gene death, thus it is nontrivial to identify true orthologs in 
related plant genomes (Schweiger et al., 2013). Moreover, individual plant UGTs 
may accept more than one substrate. For example, A. thaliana AtUGT73C5, the 
first UGT described to inactivate DON (Poppenberger et al., 2003), can also 
glycosylate brassinosteroids (Poppenberger et al., 2005), the structurally 
unrelated Fusarium toxin zearalenone (Poppenberger 2003), and regioselectively 
also quercetin at certain hydroxyl groups (Lim et al., 2004). Surprisingly, despite 
this broad activity towards multiple structurally unrelated substrates, AtUGT73C5 
does not confer NIV resistance (Fig. 1), even though only the presence of the 
C4-OH distinguishes NIV from DON. In contrast, the rice OsUGT79 can 
metabolize both DON and NIV, but not T-2 toxin (Wetterhorn et al., 2016). 
Likewise, the barley HvUGT13248 also efficiently metabolizes NIV and DON. Our 
NMR results show that the mode of NIV detoxification is analogous to that of 
DON, by exclusive formation of NIV-3-O-b-D-glucoside. The HvUGT13248 
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enzyme has higher affinity (Km value in Table 1) for NIV and about five times 
more efficiency (kcat/Km in Table 1) than with DON as the substrate.  
Inactivation of the Brachypodium gene Bradi5g03300, which is most 
similar to HvUGT13248, causes reduced resistance to Fusarium infection 
(Pasquet et al., 2016). Assuming that HvUGT13248 is also a highly relevant 
detoxification enzyme in barley, the observation of a much lower affinity of the 
enzyme towards DON than NIV suggests that the switch from the ancestral NIV 
production to DON production in Fusarium by mutation of TRI13 (Brown et al., 
2002; Lee et al., 2002) might have allowed DON to partially escape 
detoxification, providing a selective advantage to DON producers on barley. DON 
and NIV chemotype strains coexist in the field and seem to be maintained by 
balancing selection (Ward et al., 2002). We have also identified a 
glucosyltransferase from Brachypodium which confers resistance to NIV but is 
nearly inactive with DON (Wiesenberger et al., in preparation). Therefore, it is 
conceivable that differences in the detoxification capacity in various host plants 
exist, making production of either DON or NIV advantageous. Interestingly, NIV 
production has been described to be a virulence factor on maize (Maier et al., 
2006), while disruption of DON production had little effect, which could be 
explained by high DON detoxification capability. Yet, DON producers are in 
general also predominant in maize grown in Europe, North America and China 
(Kuhnem et al., 2015; Pasquali et al., 2016; Qiu and Shi, 2014), while in South 
American grown maize high frequencies of NIV producing F. meridionale and F. 
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boothii were found (Sampietro et al., 2012). Interestingly, strains have been 
reported that were genotyped as NIV producers, but produced up to 20 % DON 
besides NIV, indicating that not only complete loss of function by disrupting the 
TRI13 coding region is possible, but potentially also downregulation of the TRI13 
expression level. Overall, it seems likely that genotypic variation within different 
crop species with respect to detoxification capacity is high, and drawing 
conclusions based on one or few cultivars is premature. Currently, information on 
the detoxification capability of different cultivars is lacking in most crop plants 
infected by Fusarium ssp. 
 
Higher intrinsic plant resistance to NIV than DON 
Overexpression of HvUGT13248 provided resistance to NIV in 
Arabidopsis thaliana, alleviating the detrimental effect of the toxin on root length 
at 100 mg L-1 NIV (Fig. 3). However, compared to similar assays with DON (Shin 
et al., 2012), we found the minimal concentration required to observe root 
inhibition in the wild type Col-0 is dramatically higher for NIV (20 mg L-1no 
inhibition, Fig. 3B) than for DON (0.5 mg L-1, Shin et al., 2012). This is consistent 
with a previous report of relatively lower phytotoxicity of NIV compared to DON in 
an A. thaliana leaf assay (Desjardins et al., 2007). Similar results have been 
previously reported in wheat (Shimada and Otani, 1990), which showed severe 
wheat root growth inhibition by DON, while observing no such differences for NIV 
at the same concentrations.  
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In contrast, NIV has higher cytotoxicity than DON when applied orally to 
experimental animals, and is about 1.5 to 1.7 fold more toxic to Caco-2 human 
cells (Alassane-Kpembi et al., 2013). NIV was also shown to have greater impact 
than DON on the pig intestinal mucosa, both in vitro and in vivo (Cheat et al., 
2015). Our data obtained with the in vitro translation systems (Fig. 2 and Fig. S2) 
show that this discrepancy between plants and animals is not due to differences 
at the ribosomal target. NIV is slightly more inhibitory than DON for both rabbit 
and plant ribosomes. The difference in toxicity in plants may be in part at the 
level of uptake or drug efflux (e.g. substrate specificity for ABC transporters). Yet, 
it seems likely that the ability to glycosylate these toxins plays an important role. 
Interestingly, there is also a difference in animals. While DON is converted into 
glucuronides in pigs (and other experimental animals and humans) and in vitro 
by different UDP-glucuronosyltransferases (Maul et al., 2015), no evidence for 
formation of NIV-glucuronide was detected in a pig feeding study (Hedman et al., 
1997) and in mice treated with NIV (Poapolathep et al., 2003), which might be a 
reason for the higher toxicity of NIV in animals.  
Our data suggest that the higher basal resistance of wheat to NIV 
compared to DON directly correlates with the higher levels of NIV3G found in the 
susceptible wheat cultivar ‘Bobwhite’ compared to D3G following treatment with 
the respective toxin. Apparently, wheat has endogenous UGTs to inactivate NIV 
but a much lower capacity to detoxify DON. Constitutive expression of 
HvUGT13248 clearly increased resistance to a NIV-producing F. graminearum, 
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although the capacity to detoxify externally applied NIV was high in both parental 
and transgenic wheat. The transgenic lines converted 62.6% of the administered 
NIV into the glucoside 24 h after treatment, while ‘Bobwhite’ metabolized only 
22.7%. By 36 hours after NIV treatment, transgenic wheat converted 57.7% of 
the toxin to NIV3G, while non-transformed ‘Bobwhite’ converted 44.5% (Fig. 5 
and Table S2). In comparison, in a similar DON treatment experiment ‘Bobwhite’ 
metabolized only 2.2% DON to D3G 24 hours after treatment (Li et al., 2015). 
NIV-producing F. graminearum inoculated on transgenic wheat resulted in 
lower NIV content (and reduced fungal biomass) and a higher NIV3G to NIV ratio 
compared to non-transformed ‘Bobwhite’. One can expect that this is also the 
case in natural infection with NIV producers in the field. NIV3G is a neglected 
“masked mycotoxin” of unknown toxicological relevance. Yet, based on results of 
the reticulocyte lysates and experience from D3G in mice and pigs, resorbed 
NIV3G itself will not be toxic for mammalian ribosomes and the back-conversion 
of NIV3G to NIV by bacterial glucosidases should also take place rather late in 
the intestinal tract like demonstrated for D3G (Nagl et al., 2014), so that most of 
the released NIV should be not resorbed but excreted via feces (Gratz et al., 
2016). The lack of an analytical standard for NIV3G and the large amounts 
needed for toxicological studies have to date prevented research on this issue. 
So far only small amounts of NIV3G have been purified from NIV-contaminated 
wheat (9 mg from 12 kg starting material (Yoshinari et al., 2014)). We showed 
that NIV3G can be efficiently synthesized enzymatically in vitro with the rice 
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enzyme OsUGT79. As the reaction can be driven to completion by cofactor 
recycling (as shown for D3G, Michlmayr et al., 2015) and the reaction mix is 
much less complex, purification from this source is much easier. The described 
method can easily provide gram amounts of NIV3G for animal feeding studies, 
which will allow experimental testing of our predictions.  
 
Rapid trichothecene detoxification is key to FHB resistance 
The interaction between the fungal pathogen and the plant host is very 
dynamic. Trichothecenes play an important role in the disease spread during 
FHB development (Bai et al., 2001), and reducing trichothecenes is important to 
type II resistance (Li et al., 2015). Gene expression profiles have shown that F. 
graminearum induces trichothecene biosynthesis genes as early as 48 hours 
after germination in wheat (Lysøe et al., 2011) and Boenisch and Schafer (2013) 
reported similar timing based on microscopic examination of reporter genes. In 
barley and Brachypodium, the DON-inactivating UGTs are highly inducible by the 
toxin (Gardiner et al., 2010; Schweiger et al., 2013). Upon perception of the toxin, 
it depends on how rapidly the already partially inhibited ribosome can translate 
the induced UGT transcript into an active detoxification enzyme. If the toxin can 
be efficiently neutralized, the plant can contain the pathogen, limiting its spread. 
If the toxin diffusing ahead of the infection zone blocks or at least strongly 
reduces or severely delays translation, the plant is susceptible and the pathogen 
can spread throughout the spike. Consistent with this model, transgenic wheat 
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constitutively overexpressing HvUGT13248 efficiently converted NIV to NIV3G, 
leading to high levels of resistance to disease spread after inoculation with a NIV-
producing F. graminearum (Fig. 4, Table 2, Table S1). The ability of the 
susceptible ‘Bobwhite’ and the transgenic resistant line to convert comparable 
amounts of NIV to NIV3G at 36 hours after administering the toxin and later, 
suggests that resistance against NIV-producing chemotypes is constituted at 
earlier time points.  
With constitutive overexpression, transgenic wheat expressing 
HvUGT13248 provides resistance to both DON and NIV and does therefore not 
seem to be at risk to be easily overcome by a shift in chemotype composition, 
and thus is an excellent candidate gene for FHB control also in regions of the 
world where NIV-producing species are highly prevalent. 
  93 
Table 3.1. Biochemical characterization of recombinant UDP-
glucosyltransferases from rice (nHis6-MalE-OsUGT79) and barley (nHis6-MalE-
HvUGT13248).  
Catalyst Substrate KM (mM) Vmax (µmol 
min-1 mg-1) 
kcat kcat/KM 
HvUGT13248 deoxynivalenol 3.0 ± 0.6 0.49 ± 0.04 > 0.78 > 0.26 
 nivalenol 1.2 ± 0.3 0.96 ± 0.06 > 1.5 > 1.3 
OsUGT79 deoxynivalenol* 0.23 ± 0.06 0.36 ± 0.02 0.57 2.5 
 nivalenol 0.35 ± 0.04 0.38 ± 0.01 0.60 1.7 
 
The displayed values are the results of three independent measurements ± 
standard deviations.  
*Reported in Michlmayr et al., 2015. 
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Table 3.2. Trichothecene accumulation and ergosterol content in NIV-producing 
F. graminearum inoculated wheat spikes.  
Genotypea Ergosterol (mg L-1) NIV (mg L-1) DON (mg L-1) 
#8 
#15 
#19 
#37 
Bobwhite 
Wheaton 
Sumai 3 
5.38 ± 1.58*** 
1.37 ± 0.50*** 
1.85 ± 0.05*** 
1.08 ± 0.20*** 
49.53 ± 6.95 
54.88 ± 4.23 
0.90 ± 0.02 
4.70 ± 0.50*** 
2.00 ± 0.31*** 
3.03 ± 0.58*** 
1.80 ± 0.06*** 
29.57 ± 5.82 
47.43 ± 2.16 
0.58 ± 0.02 
ndb 
nd 
nd 
nd 
0.28 ± 0.06 
0.29 ± 0.02 
nd 
 
a#8, #15, #19 and #37 were transgenic lines, and ‘Bobwhite’ was the non-
transformed control. ‘Sumai 3’ was the resistant check, and ‘Wheaton’ was the 
susceptible check.  
bnd: not detected (less than 0.05 mg L-1). 
Values provided are the means ± standard error.  
*, ** and *** indicate significance at the 0.05, 0.01, and 0.001 levels compared 
with the non-transformed ‘Bobwhite’ control (Student’s t test). 
  95 
Figure 3.1. Growth of glycosyltransferase expressing yeast on rich medium 
containing the indicated concentrations of DON and NIV. 
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Figure 3.2. NIV-3-glucoside is less toxic than NIV and DON on wheat ribosomes. 
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Figure 3.3. Root growth of transgenic Arabidopsis thaliana expressing 
HvUGT13248 in the Col-0 background on half strength MS medium containing 
(A) 0 mg L-1 NIV, (B) 20 mg L-1 NIV, (C) 40 mg L-1 NIV and (D) 100 mg L-1 NIV. 
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Figure 3.4. FHB severity of transgenic wheat expressing HvUGT13248 at 21 
days after point inoculation with NIV-producing F. graminearum strain #02-15 in 
three greenhouse trials. Lines #8, #15, #19 and #37 were transgenic wheat 
expressing HvUGT13248 and ‘Bobwhite’ was the non-transformed control. 
‘Wheaton’ was the susceptible check and ‘Sumai 3’ was the resistant check. 
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Figure 3.5. HvUGT13248 promotes NIV to NIV3G conjugation in transgenic 
wheat. (A) NIV and NIV3G concentrations in ‘Bobwhite’ (BW) and transgenic line 
#19 at 0, 2, 6, 12, 24, 36, 48, 72, 96, and 336 hours after NIV treatment. ‘BW-
NIV’ and ‘UGT-NIV’ are the NIV content in BW or transgenic event #19 at each 
time point, respectively. ‘BW-NIV3G’ and ‘UGT-NIV3G’ are the NIV3G content in 
BW or transgenic line #19 at each time point, respectively. (B) Fold change of 
molar ratio of NIV3G to NIV concentrations in BW and transgenic line #19 at 
each time point. 
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Supplementary Table S3.1. Summary of transgenic wheat expressing HvUGT13248 in greenhouse point-inoculation 
tests with NIV-producing F. graminearum strain. 
 2013 Spring 2013 Fall 2014 Fall 
Genotypea No.b Sev.c (%) Red.d (%) No. Sev. (%) Red. (%) No. Sev. (%) Red. (%) 
#8 31 8.2 ± 0.8*** 75.4 27 20.2 ± 4.0*** 71.1 16 9.4 ± 0.9*** 83.8 
#15 32 6.8 ± 0.1*** 79.5 27 7.3 ± 0.1*** 89.6 14 9.6 ± 1.1*** 83.4 
#19 20 6.7 ± 0.2*** 79.9 18 7.9 ± 0.5*** 88.6 14 15.1 ± 2.6*** 73.9 
#37 31 6.9 ± 0.3*** 79.3 27 6.8 ± 0.1*** 90.3 16 13.2 ± 1.9*** 77.1 
Bobwhite 22 33.2 ± 6.6 NAe 25 69.8 ± 5.0 NA 16 57.7 ± 4.4 NA 
Wheaton 23 58.6 ± 7.3 NA 20 82.9 ± 6.4 NA 15 86.9 ± 5.2 NA 
Sumai 3 22 8.0 ± 1.3 NA 18 7.0 ± 1.6 NA 18 6.5 ± 0.6 NA 
 
aEvents #8, #15, #19 and #37 were transgenic lines, and ‘Bobwhite’ was the non-transformed control. ‘Sumai 3’ was the 
resistant check, and ‘Wheaton’ was the susceptible check. Values provided are the means ± standard error.  
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*, ** and *** indicate significance at the 0.05, 0.01, and 0.001 levels compared with the non-transformed ‘Bobwhite’ control 
(Student’s t test). 
bNo.: number of plants examined in the disease screen. cSev.: FHB severity shown as the percentage of symptomatic 
spikelets in the inoculated spikes. dRed.: percent disease reduction rate as compared to the corresponding non-
transformed ‘Bobwhite’ control. eNA: not applicable. 
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Table S3.2. HvUGT13248 converts NIV to NIV3G faster in transgenic wheat than in non-transformed ‘Bobwhite’. 
Numbers shown are mean value ± standard error. *, ** and *** indicate significance at the 0.05, 0.01, and 0.001 levels 
compared with the non-transformed ‘Bobwhite’ control (Student’s t test). 
 Non-transformed ‘Bobwhite’ HvUGT13248-#19 transgenic wheat 
Timea 
(h) 
NIV (nmol) NIV3G 
(nmol) 
NIV3G/ NIVb NIV+NIV3Gc 
(nmol) 
NIV (nmol) NIV3G (nmol) NIV3G/ NIV NIV+NIV3G 
(nmol) 
0 106.69 ± 7.17 0 0 106.69 ± 7.17 83.57 ± 5.82* 0 0 83.57 ± 5.82* 
2 87.89 ± 3.40 0.44 ± 0.11 0.01 ± 0 88.39 ± 3.39 75.06 ± 3.13* 2.52 ± 0.22*** 0.03 ± 0*** 77.58 ± 3.32* 
6 120.45 ± 6.18 5.02 ± 0.44 0.04 ± 0 125.47 ± 6.20 85.96 ± 5.85** 19.20 ± 2.11*** 0.22 ± 0.02*** 105.16 ± 7.20 
12 66.92 ± 5.05 16.37 ± 0.77 0.26 ± 0.02 83.29 ± 5.22 70.35 ± 7.90 23.41 ± 1.90** 0.36 ± 0.05 93.75 ± 7.91 
24 59.55 ± 8.95 24.24 ± 1.57 0.45 ± 0.04 83.79 ± 9.64 49.13 ± 4.13 52.28 ± 2.97*** 1.11 ± 0.09*** 101.41 ± 5.84 
36 35.04 ± 2.55 47.53 ± 1.60 1.40 ± 0.09 82.56 ± 3.26 33.44 ± 3.33 48.19 ± 3.44 1.59 ± 0.20 81.63 ± 2.60 
48 27.64 ± 4.62 53.62 ± 2.76 2.20 ± 0.24 81.26 ± 6.64 19.84 ± 2.29 55.47 ± 2.19 3.10 ± 0.36 75.31 ± 2.33 
72 18.76 ± 2.22 51.34 ± 1.72 2.99 ± 0.32 70.10 ± 2.83 20.52 ± 2.42 63.18 ± 2.49** 3.31 ± 0.29 74.40 ± 10.09* 
96 15.58 ± 1.92 56.89 ± 3.61 3.91 ± 0.33 64.42 ± 9.23 10.45 ± 1.41* 52.71 ± 3.13 6.24 ± 1.21 63.16 ± 3.31 
336 5.41 ± 0.89 61.75 ± 2.43 13.40 ± 1.87 59.70 ± 7.87 10.35 ± 1.83* 64.12 ± 4.25 7.72 ± 1.30* 66.20 ± 9.47 
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aTime after NIV treatment when samples were collected. 
bRatio of NIV3G over NIV at each time point in each genotype. 
cSum of NIV3G and NIV at each time point in each genotype. 
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Supplementary Figure S3.1. NMR data of NIV-3-O-β-D-glucoside. 1H, 13C and correlated spectra revealing NIV3G as the 
only product of NIV detoxification by OsUGT79 and HvUGT13248. All chemical shifts are displayed on the x-axis and are 
given in ppm relative to tetramethylsilane. The calibration was done using residual solvent signals methanol-d4). 
Multiplicities are abbreviated as s (singlet), d (doublet), t (triplet), q (quartet) and b (broad signal).  
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a)  1H spectrum of NIV-3-β-D-glucoside 
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1H NMR (400 MHz, methanol-d4) δ 6.61 (b, 1H), 4.82 (b, 1H), 4.69 (b, 1H), 4.66 (b, 1H), 4.63 (d, J=7.6 Hz, 1H), 4.31 (dd, 
J=4.5, 3.7 Hz, 1H), 3.88 (dd, J=12.0, 2.1 Hz, 1H), 3.77 (d, J=4.1 Hz, 1H), 3.71 (dd, J=12.1, 5.0 Hz, 1H), 3.70 – 3.90 (m, 
2H), 3.40 (t, J=7.9 Hz, 1H), 3.37 (t, J=8.5 Hz, 1H), 3.31 (b, 1H), 3.29 (b, 1H), 3.02 (b, 2H), 1.84 (s, 3H), 1.11 (s, 3H) 
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13C spectrum of NIV-3-β-D-glucoside 
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13C NMR (100 MHz, methanol-d4) δ 200.1 (s, 1C), 137.5 (d, 1C), 136.1 (s, 1C), 102.7 (d, 1C), 85.8 (d, 1C), 80.0 (d, 1C), 
78.0 (d, 1C), 76.7 (d, 2C), 74.0 (d, 1C), 73.5 (d, 1C), 69.9 (d, 1C), 69.6 (d, 1C), 64.5 (s, 1C), 61.1 (t, 1C), 60.0 (t, 1C), 53.3 
(s, 1C), 48.8 (s, 1C), 45.1 (t, 1C), 13.8 (q, 1C), 6.9 (q, 1C) 
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b) H-H-COSY spectrum of NIV-3-β-D-glucoside 
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c) HSQC spectrum of NIV-3-β-D-glucoside with 1H on the x-axis and 13C on the y-axis 
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d) HMBC spectrum of NIV-3-β-D-glucoside with 1H on the x-axis and 13C on the y-axis. The arrows indicate the connection 
between position 3 of DON and position 1’ of glucose - red arrow = 85.8/4.63 ppm; blue arrow = 102.7/4.31 ppm. 
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Figure S3.2. NIV-3-glucoside is less inhibitory than NIV for rabbit reticulocyte 
ribosomes. 
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Figure S3.3. Root growth of Col-0 wildtype and transgenic A. thaliana expressing 
HvUGT13248 on half strength MS medium containing 0 mg L-1 NIV at 7 days and 
100 mg L-1 NIV at 14 days after germination. Scale bars = 2 cm. 
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Appendix 1: Introducing and characterizing HvUGT13248 in elite wheat 
cultivars ‘Rollag’ and ‘Linkert’ 
Introduction 
Breeders and geneticists have screened numerous germplasm collections 
and identified accessions that harbor partial resistance to FHB. These resistance 
sources have been used in QTL mapping studies to uncover loci that confer 
partial quantitative resistance. One of these QTL is Fhb1, which is a major QTL 
that confers type II resistance, that has been introgressed into breeding 
programs worldwide. Although breeding programs have been making progress in 
developing FHB resistant cultivars, the level of protection is insufficient in a high 
disease environment. Thus, there is a need to incorporate genes from other 
species to increase resistance. 
 Two recently released cultivars from the University of Minnesota hard red 
spring wheat breeding program are ‘Rollag’ and ‘Linkert’. ‘Rollag’ exhibits 
moderate resistance to FHB and contains Fhb1, whereas ‘Linkert’ exhibits 
moderate susceptibility to moderate resistance and does not contain Fhb1. 
HvUGT13248 provides a high level of type II resistance in transgenic wheat (Li et 
al., 2015). Thus, we introgressed HvUGT13248 into ‘Rollag’ and ‘Linkert’ and 
tested these lines for resistance to FHB. These genetic stocks provided the tools 
to answer two questions: (1) does combining two genes (Fhb1 and 
HvUGT13248) that confer type II resistance confer an additive increase in FHB 
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resistance; and (2) does introgressing HvUGT13248 into elite lines result in 
increased FHB resistance.  
 
Materials and Methods 
‘Rollag’ and ‘Linkert’ are recently released elite wheat cultivars from the 
University of Minnesota Agricultural Experiment Station (Anderson et al., 2015; 
https://www.extension.umn.edu/agriculture/small-grains/cultivar-selection-and-
genetics/docs/spring-wheat-cultivar-linkert.pdf). Both cultivars exhibit excellent 
agronomic traits. ‘Rollag’, carries Fhb1 and shows a moderately resistant FHB 
phenotype, and ‘Linkert’ does not carry Fhb1 and exhibits a moderately 
susceptible to moderately resistant phenotype.  
Four transgenic events (#8, #14, #15 and #37) in the ‘Bobwhite’ genetic 
background that carried HvUGT13248 were crossed to ‘Linkert’. The resulting ten 
to 24 F1 seeds of the four transgenic families were grown and tested for 
HvUGT13248 gene expression by ELISA with the NPTII antibody. The F1 plants 
were then crossed to ‘Linkert’ again. For each backcross, three to six BC1F1 
seeds were obtained. The BC1F1 plants were grown and tested for HvUGT13248 
gene expression by ELISA with the NPTII antibody. A total of 16 BC1F1 plants of 
the four families that were UGT+ were allowed to self-pollinate and the 
subsequent BC1F2 plants were genotyped for the presence or absence of 
HvUGT13248 by ELISA assay. At BC1F3 generation, homozygous lines were 
identified from three to four different BC1F2 lines which were generated from at 
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least two different BC1 crosses of each transgenic events. Three UGT+ and three 
UGT- homozygous lines of each family were selected and maintained by self-
pollination for further experiments (Table A1.1).  
Similarly, the introgression of HvUGT13248 to elite cultivar ‘Rollag’ was 
performed (Table A1.2) by crossing four transgenic events (#8, #14, #15 and 
#19) with ‘Rollag’. The resulting two to nine F1 seeds of the four transgenic 
families were grown and tested for HvUGT13248 gene expression by ELISA with 
the NPTII antibody. The F1 plants were then crossed to ‘Rollag’ again and 78 
BC1F1 plants were obtained. Within the 54 UGT+ BC1F1s, one cross of each 
transgenic family was selected and self-pollinated to obtain BC1F2 plants. Forty 
eight of individuals from each of these four lines were genotyped for the Fhb1 
QTL by three nearby SNP markers: gwm533, gwm493 and barc133 (Dr. 
Shiaoman Chao at USDA, Fargo, ND), and HvUGT13248 expression was tested 
by ELISA. At this stage, four genetic classes were selected: UGT+/Fhb1R (UGT+; 
Fhb1+/+); UGT+/FHb1S (UGT+; Fhb1-/-); UGT-/Fhb1R (UGT-/-; Fhb1+/+); UGT-
/FHb1S (UGT-/-; Fhb1-/-). Homozygosity of HvUGT13248 was determined in 
BC1F3 families and two to three homozygous lines of all four genotypes of the 
four transgenic families were identified and advanced to the BC1F4 for further 
experiments (Fig. A1.2). 
For greenhouse point inoculation, seeds were planted into Sunshine MVP 
growth medium (Sun Gro Horticulture, Agawam, MA, USA) in 6-inch square 
plastic pots in a greenhouse. Twelve to Twenty-four seeds were planted for each 
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genotype with each pot containing four seeds. Plants were fertilized with one 
teaspoon of Osmocote (14-14-14 N-P-K, Scotts Company, Marysville, OH) 
fertilizer per pot at the 3-leaf stage. At anthesis, one floret of a central spikelet of 
the main spike was inoculated with 10 µL of macroconidial suspension (105 
macroconidia mL-1 and 0.01% Triton X-100) of F. graminearum (Dr. Ruth Dill-
Macky, Department of Plant Pathology, University of Minnesota). Inoculated 
spikes were covered with transparent plastic bags for 3 days. FHB disease 
severity was determined as the percentage of spikelets with disease symptoms 
on the inoculated spikes at 21 days after inoculation. 
 
Results and Discussion 
The ‘UGT x Rollag’ and ‘UGT x Linkert’ BC1F4 populations were tested for 
FHB severity in the greenhouse by point inoculation with F. graminearum. The 
FHB severity scores of the susceptible checks ‘Wheaton’ and ‘Norm’ were 69.1% 
± 12.8% and 86.4% ± 13.6%, respectively; while the resistant check ‘Sumai 3’ 
showed 7.2% ± 1.4%, indicating the environment of the greenhouse trial was 
discriminative. The FHB severity of the transgenic parental lines (#8, #14, #15 
and #37) ranged between 7.8% to 10.7%, while the two recurrent parental lines 
‘Rollag’ and ‘Linkert’ exhibited 11.6% and 21.1%, respectively (Table A1.1 and 
Table A1.2, Fig. A1.3 and Fig. A1.4). 
For ‘UGT x Linkert’ derived lines, all UGT+ lines exhibited severity levels 
that were significantly lower than the susceptible parent ‘Linkert’ except for two 
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lines (#14-18-3-9-326 and #15-8-1-7-555). All ‘UGT-’ sibling lines show FHB 
severity similar to or higher than ‘Linkert’ (Table A1.1 and Fig. A1.3). Therefore, 
introgressing HvUGT13248 to elite cultivar ‘Linkert’ increased FHB type II 
resistance. 
For the ‘UGT x Rollag’ BC1F4 lines, four different genotypes (UGT+/Fhb1R 
(UGT+; Fhb1+/+); UGT+/FHb1S (UGT+; Fhb1-/-); UGT-/Fhb1R (UGT-/-; 
Fhb1+/+); UGT-/FHb1S (UGT-/-; Fhb1-/-)) were tested. For the greenhouse trial, 
#15- and #19-derived lines were tested for FHB severity. Among the four 
genotypes, the UGT+/Fhb1R genotype was the most resistant, and the FHB 
severity was lower than the recurrent parent ‘Rollag’, although the differences 
were not significant. The UGT-/FHb1S genotype was the most susceptible. For 
the lines carrying either the HvUGT13248 gene or Fhb1, the FHB severity levels 
were also lower than UGT-/FHb1S (Table A1.2 and Fig. A1.4). ‘Rollag’ exhibits 
type II resistance, mainly contributed by the Fhb1 QTL, so the improvement of 
type II resistance after introducing HvUGT13248 gene is marginal. Such effect is 
also observed when comparing UGT+/Fhb1R (UGT+; Fhb1+/+) with UGT-/FHb1R 
(UGT-; Fhb1+/+) genotypes in the #15 and #19 derived lines (Table A1.2 and 
Fig. A1.4). The average FHB severity of UGT+/Fhb1R in the #15 derived lines 
were lower than UGT-/FHb1R, but the differences were not significant. For #19 
derived lines, UGT+/Fhb1R genotype exhibited a significantly lower FHB severity 
compared to UGT-/FHb1R, but we cannot precisely account for the contributions 
of the 25% genome of susceptible cultivar ‘Bobwhite’ that was introgressed 
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during the backcross. So, in the current settings, introgressing HvUGT13248 did 
not further improve the type II resistance levels when Fhb1 already exists. More 
challenging environments (field trials) may overwhelm the protection by Fhb1, 
and DON accumulation analysis after field trials will give us more information 
about DON and FHB resistance contributed by HvUGT13248 in the ‘Rollag’ 
background. 
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Table A1.1. FHB severity of ‘UGT x Linkert’ lines at 21 days after point 
inoculation with F. graminearum in a greenhouse trial. Transgenic events #8, 
#14, #15 and #37 derived BC1F4 generation that were homozygous for 
HvUGT13248 (UGT+) or lines that were segregated without HvUGT13248 
expression (UGT-) were tested. 
Line UGT No. Severity (%) Reduction (%) 
#8 + 24 10.7 ± 2.2 NA 
8-1-6-10-20 + 13 12.7 ± 2.3* 40.1 
8-5-1-4-124 + 6 10.3 ± 1.7* 51.5 
8-5-1-4-129 + 11 9.6 ± 1.4** 54.7 
8-4-2-4-91 - 14 20.4 ± 6.8 3.7 
8-5-1-8-163 - 13 38.2 ± 10.0 -80.7 
#14 + 24 7.8 ± 0.6 NA 
14-18-3-9-326 + 14 14.4 ± 3.9 31.7 
14-19-1-4-371 + 12 8.7 ± 0.8*** 59.0 
14-19-3-9-440 + 10 8.6 ± 0.4** 59.3 
14-18-1-2-285 - 8 28.1 ± 10.3 -33.0 
#15 + 24 7.9 ± 0.5 NA 
15-8-1-7-554 + 6 10.8 ± 1.3* 48.9 
15-8-1-7-555 + 10 18.6 ± 4.6 11.8 
15-15-5-4-513 - 10 30.7 ± 6.0 -44.9 
15-2-7-5-639 - 15 27.4 ± 5.5 -29.4 
#37 + 31 8.8 ± 0.6 NA 
37-12-1-6-719 + 8 10.5 ± 1.7* 50.4 
37-13-1-11-826 + 17 8.7 ± 0.5*** 59.0 
37-14-1-7-929 + 14 10.1 ± 1.0** 52.3 
37-12-1-9-748 - 14 74.7 ± 10.0 -253.1 
37-12-1-9-753 - 15 64.9 ± 10.1 -206.8 
37-13-1-11-821 - 10 27.3 ± 6.2 -29.0 
Linkert - 24 21.1 ± 2.6  
Wheaton - 9 69.1 ± 12.8  
Norm - 8 86.4 ± 13.6  
Sumai 3 - 8 7.2 ± 1.4  
Rollag - 20 11.6 ± 1.4  
 
No.: number of plants examined in the disease screen 
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UGT: Positive (+) and negative (-) indicate expression or not of the HvUGT13248 
transgene. 
FHB severity: percentage of symptomatic spikelets in the inoculated spikes. 
Reduction: percentage of FHB severity reduction rate as compared to the 
parental line 'Linkert'. 
*, ** and *** indicate significance of FHB severity reduction at the 0.05, 0.01, and 
0.001 levels compared with the parental line 'Linkert'. 
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Table A1.2. FHB severity of ‘UGT x Rollag’ lines at 21 days after point 
inoculation with F. graminearum in a greenhouse trial. Transgenic events #15 
and #19 derived BC1F4 generation of the following four genotypes were tested: 
UGT+/Fhb1R (UGT+; Fhb1+/+); UGT+/FHb1S (UGT+; Fhb1-/-); UGT-/Fhb1R 
(UGT-/-; Fhb1+/+); UGT-/FHb1S (UGT-/-; Fhb1-/-). C1 to C12 were #15 derived 
lines, and D1 to D11 were #19 derived lines. 
 
Line Genotype No. Severity (%) 
#15 UGT+/Fhb1S 24 7.9 ± 0.5 
C1 UGT+/Fhb1R 12 8.5 ± 0.9 
C2 UGT+/Fhb1R 13 8.0 ± 0.9 
C3 UGT+/Fhb1R 8 10.2 ± 2.4 
C4 UGT-/Fhb1R 14 19.7 ± 5.0 
C5 UGT-/Fhb1R 16 8.6 ± 0.8 
C6 UGT+/Fhb1S 6 20.5 ± 5.2 
C7 UGT+/Fhb1S 13 13.2 ± 2.5 
C9 UGT+/Fhb1S 9 19.9 ± 5.8 
C10 UGT-/Fhb1S 10 24.5 ± 3.2 
C11 UGT-/Fhb1S 13 38.9 ± 6.0 
C12 UGT-/Fhb1S 13 35.3 ± 5.7 
#19 UGT+/Fhb1S 13 10.1 ± 1.5 
D1 UGT+/Fhb1R 6 7.7 ± 0.6 
D2 UGT+/Fhb1R 8 8.1 ± 0.4 
D3 UGT+/Fhb1R 6 8.1 ± 1.0 
D4 UGT-/Fhb1R 15 13.4 ± 3.4 
D6 UGT-/Fhb1R 20 25.4 ± 4.8 
D7 UGT+/Fhb1S 6 14.5 ± 6.3 
D8 UGT+/Fhb1S 6 8.1 ± 0.6 
D9 UGT+/Fhb1S 6 7.7 ± 0 
D10 UGT-/Fhb1S 8 17.9 ± 5.7 
D11 UGT-/Fhb1S 12 27.5 ± 5.2 
Rollag UGT-/Fhb1R 20 11.6 ± 1.4 
Wheaton UGT-/Fhb1S 9 69.1 ± 12.8 
Norm UGT-/Fhb1S 8 86.4 ± 13.6 
Sumai 3 UGT-/Fhb1R 8 7.2 ± 1.4 
 
No.: number of plants examined in the disease screen 
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FHB severity: shown as the percentage of symptomatic spikelets in the 
inoculated spikes. 
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Figure A1.1. Development of ‘UGT x Linkert’ backcross lines. Homozygous lines 
with (UGT+/+) or without HvUGT13248 (UGT-/-) were identified at BC1F3 
generation and were self-pollinated. At BC1F4 generation, plants were point 
inoculated with F. graminearum in the greenhouse to evaluate FHB severity 
levels. 
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Figure A1.2. Development of ‘UGT x Rollag’ backcross lines. ELISA with NPTII 
antibody was performed at every generation to detect presence or absence of 
HvUGT13248. At BC1F2 generation, three SNP markers (gwm533, gwm493 and 
barc133) were tested to determine the Fhb1 QTL. At BC1F3 generation, 
homozygosity of HvUGT13248 was determined by segregation patterns. Four 
genetic classes were selected: UGT+/Fhb1R (UGT+/+; Fhb1+/+); UGT+/FHb1S 
(UGT+/+; Fhb1-/-); UGT-/Fhb1R (UGT-/-; Fhb1+/+); UGT-/FHb1S (UGT-/-; Fhb1-
/-). 
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Fig. A1.3. FHB severity of ‘UGT x Linkert’ lines at 21 days after point inoculation 
with F. graminearum in a greenhouse trial. Transgenic events #8 (A), #14 (B), 
#15 (C) and #37 (D) derived BC1F4 families that were homozygous for 
HvUGT13248 (UGT+) or lines that were segregated without HvUGT13248 
expression (UGT-) were tested.  
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Fig. A1.4. FHB severity of ‘UGT x Rollag’ lines at 21 days after point inoculation 
with F. graminearum in a greenhouse trial. Transgenic event #15- and #19- 
derived BC1F4 families were tested. (A) For #15 derived lines, lines of four 
different genotypes were tested: C1, C2 and C3 were three different lines with 
HvUGT13248 and the resistant allele of Fhb1 QTL (UGT+/Fhb1R); C4 and C5 
were lines without HvUGT13248 and carrying the resistant allele of Fhb1 (UGT-
/Fhb1R); C6, C7 and C9 were lines were UGT+ and carrying the susceptible 
allele of Fhb1 QTL (UGT+/Fhb1S); and C10, C11 and C12 were UGT-/Fhb1S. (B) 
For #19 derived lines, D1, D2 and D3 were UGT+/Fhb1R; D4 and D6 were UGT-
/Fhb1R; D7, D8 and D9 were UGT+/Fhb1S; while D10 and D11 were UGT-
/Fhb1S. 
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Appendix 2: HvUGT13248 provides resistance to a wide spectrum of 
trichothecene chemotypes 
Introduction 
Trichothecenes consist of a diverse group of chemotypes which carry 
small substitutions mainly at C-3, C-4, C-7, C-8 and C-15 positions (Figure 1.1). 
Although being similar in structure, various trichothecene chemotypes have been 
reported to have a wide range of toxic levels in different organisms (Wakulinski, 
1989; Shimada and Otani, 1990; Eudes et al., 2000; Desjardins et al., 2007). In 
Chapter 2 and Chapter 3, transgenic plants expressing HvUGT13248 were 
shown to detoxify DON and NIV to D3G and NIV3G, respectively. Interestingly, 
the detoxification ability of HvUGT13248 to these two chemotypes is different.  
Recently, a new type of F. graminearum produced trichothecene 
mycotoxins were identified as NX-2 (Varga et al., 2015). NX-2 is a type A 
trichothecene that lacks a keto group at C-8 position on the trichothecene 
backbone (Fig. 1.1). The Arabidopsis DOGT1 gene capable of detoxifying DON 
showed no resistance to a type A toxin DAS (diacetoxyscirpenol) in transgenic 
yeast (Poppenberger et al., 2003). Moreover, NX-2 toxin is occupied by an acetyl 
group at C-3 position, which may block the glucosyltransferation catalyzed by 
HvUGT13248. 
To test whether HvUGT13248 also provides resistance to NX-2, we 
performed point inoculation experiments on transgenic wheat expressing 
HvUGT13248 with an NX-2 producing F. graminearum strain. We also performed 
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an inoculation on the same materials with a 3-ADON producing F. graminearum 
strain to test the influence of C-3 position acetylation to the detoxification ability 
of HvUGT13248. This is of particular interest because recent reports indicate an 
obvious shift of chemotypes favoring 3-ADON producing strains in North America 
and Asia (Ward et al., 2008; Zhang et al., 2010; Zhang et al., 2012). 
Similarly, a NIV acetyl derivative, 3,15-diANIV, was reported to be at least 
40 times more toxic to Arabidopsis thaliana than NIV (Desjardins et al., 2007). 
3,15-diANIV is a precursor of NIV in the trichothecene biosynthetic pathway 
(McCormick et al., 2011). In Chapter 3, HvUGT13248 was shown to provide high 
levels of resistance to NIV and an NIV-producing F. graminearum strain. To 
further test the detoxification ability of HvUGT13248 to the more toxic derivative 
of NIV, 3,15-diANIV, which also carries a C-3 acetyl group, we conducted root 
growth assay of transgenic Arabidopsis thaliana and wheat overexpressing 
HvUGT13248 on growth medium containing different concentrations of 3,15-
diANIV. 
 
Results and Discussion 
Transgenic wheat expressing HvUGT13248 provide resistance to NX-2 and 3-
ADON producing F. graminearum 
Point inoculation tests were performed on transgenic wheat expressing 
HvUGT13248 with 3-ADON or NX-2 producing F. graminearum strains (obtained 
from Dr. Corby H. Kistler at USDA-ARS and Department of Plant Pathology, 
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University of Minnesota). Eight to twenty plants of transgenic wheat carrying 
HvUGT13248 (Chapter 2), ‘Bobwhite’, ‘Sumai 3’, ‘Rollag’, ‘Norm’ and ‘Wheaton’, 
were evaluated for type II resistance. Plants expressing the transgene were 
detected based on ELISA assays (Agdia Inc, Elkhart, IN, USA) with NPTII 
antibody as described in Chapter 2. Point inoculation tests were carried out 
according to Chapter 2 and 3. 
When testing the NX-2 producing F. graminearum strain, the susceptible 
check ‘Wheaton’ and ‘Norm’ exhibited FHB severity levels of 85.4 ± 5.7% and 
72.4 ± 10.3%, respectively; while the resistant check ‘Sumai 3’ and ‘Rollag’ 
exhibited FHB severity levels of 12.0 ± 2.5% and 10.0 ± 2.6%, respectively, 
indicating the environments for FHB severity screening were successful and 
discriminative (Fig. A2.1). Transgenic line #8 showed FHB severity of 11.2 ± 
2.6%, #14 showed FHB severity of 6.4 ± 0.1%, #15 showed 7.6 ± 0.3% severity, 
#19 showed 7.0 ± 0.1% severity, #34 showed FHB severity of 8.5 ± 1.0%, and 
#37 showed 7.0 ± 0.4% severity. All six transgenic lines exhibited significant 
reduction of FHB severity relative to ‘Bobwhite’ by 73 - 85%, and all the 
transgenic lines showed FHB severity at levels comparable to or even lower than 
the resistant checks. 
In a similar experiment, 3-ADON producing F. graminearum conidia were 
point inoculated on the same set of wheat plants. The susceptible checks 
‘Wheaton’ and ‘Norm’ exhibited FHB severity levels of 73.6 ± 6.0% and 63.5 ± 
7.0%, respectively; while the resistant checks ‘Sumai 3’ and ‘Rollag’ exhibited 
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FHB severity levels of 6.6 ± 0.9% and 8.4 ± 0.3%, respectively (Fig. A2.2). 
Transgenic line #8 showed FHB severity of 13.4 ± 3.3%, #14 showed FHB 
severity of 11.7 ± 3.4%, #15 showed 7.2 ± 1.2% severity, #19 showed 13.9 ± 
7.2% severity, #34 showed FHB severity of 17.2 ± 5.0%, and #37 showed 7.4 ± 
1.4% severity. All six transgenic lines exhibited significant reduction of FHB 
severity relative to ‘Bobwhite’ by 61 - 84%, and two transgenic lines (#15 and 
#37) showed FHB severity at similar levels to the resistant checks. 
Taken together, transgenic wheat expressing HvUGT1348 exhibited high 
levels of type II resistance to 3-ADON and NX-2 producing F. graminearum 
strains. The exact detoxified forms are not known, but Varga et al. (2015) 
reported that wheat ears accumulated 10 times higher amount of NX-3 
(deacetylated NX-2) than NX-2 after NX-2 F. graminearum inoculation. It is also 
known that 3-ADON producers accumulated high concentrations of DON in plant 
tissues (Alexander et al., 2011; Miedaner et al., 2001; von der Ohe et al., 2010).  
Schmeitzl et al. (2016) reported Brachypodium distachyon carboxylesterases 
efficiently deacetylate NX-2 to NX-3, and 3-ADON to DON. It is highly possible 
that wheat and barley plants incorporate similar mechanisms to quickly 
deacetylate C-3 acetylated trichothecenes, leaving the products available for 
UGTs to catalyze the addition of a glucoside group to the C-3 position. 
 
Appendix 2.2. HvUGT13248 transgenic Arabidopsis and wheat show 
resistance to root growth inhibition caused by 3,15-diANIV. 
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3,15-diANIV is a NIV-derivative with super toxic effect to Arabidopsis 
thaliana (Desjardins et al., 2007). To investigate whether HvUGT13248 provides 
resistance to 3,15-diANIV in plants, we tested transgenic A. thaliana expressing 
HvUGT13248 on 3,15-diANIV-supplemented growth medium (Fig. A2.3) (3,15-
diANIV obtained from Dr. Susan McCormick at USDA-ARS Mycotoxin Prevention 
and Applied Microbiology Research Lab at Peoria, IL). Two transgenic lines (#40 
and #42) previously reported by Shin et al., (2012), along with a non-transformed 
‘Col-0’ control, were grown on MS medium supplemented with 0, 10 or 20 mg L-1 
3,15-diANIV. The results show that in the control treatment (0 mg L-1 3,15-
diANIV), root lengths of the transgenic lines were not significantly different from 
the non-transformed ‘Col-0’ (Fig. A2.3 A and D). When grown on medium 
containing 10 or 20 mg L-1 3,15-diANIV, the roots of both transgenic lines were 
significantly longer than ‘Col-0’ (Fig. A2.3 B to D). Using GC-MS (Dr. Yanhong 
Dong, Department of Plant Pathology, University of Minnesota), 0.94 ppm and 
1.5 ppm of 3,15-diANIV were detected in the shoot of transgenic line #42 and 
#40, compared to 13.6 ppm of 3,15-diANIV in non-transformed ‘Col-0’ control 
(Figure A2.3 E). 
A similar test was also performed on transgenic wheat. Three transgenic 
lines (#8 #15 and #37, as described in Chapter 2), along with a non-transformed 
‘Bobwhite’ control, were grown on MS medium supplemented with 0 or 10 mg L-1 
3,15-diANIV. The results show that in the control treatment, root length of the 
transgenic lines were not significantly different from the non-transformed ‘BW’ 
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(Figure A2.4 A). When grown on medium containing 10 mg L-1 3,15-diANIV, the 
roots of all three transgenic lines were significantly longer than ‘Col-0’ (Figure 
A2.4 B). 
Therefore, transgenic Arabidopsis thaliana and wheat expressing 
HvUGT13248 show resistance to 3,15-diANIV. The toxin content analysis on the 
Arabidopsis plants grown on 3,15-diANIV containing medium (Fig. A2.3E) is of 
particular interest. The results clearly indicated that 3,15-diANIV was transported 
into plants, and was accumulated much less in the two transgenic lines 
overexpressing HvUGT13248. The mechanism of resistance is probably similar 
to the previously discussed NX-2 and 3-ADON. But clear elucidation of the 
detoxified forms of 3,15-diANIV is necessary to draw a conclusion. 
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Fig. A2.1. HvUGT13248 exhibit significantly reduced FHB serverity in transgenic 
wheat when inoculated with NX-2 producing Fg strain #06-205. ** and *** 
indicate significance at the 0.01, and 0.001 levels compared with the non-
transformed ‘Bobwhite’ control (Student’s t test). 
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Fig. A2.2. HvUGT13248 exhibit significant reduced FHB serverity in transgenic 
wheat when inoculated with 3-ADON producing Fg strain. ** and *** indicate 
significance at the 0.01, and 0.001 levels compared with the non-transformed 
‘Bobwhite’ control (Student’s t test). 
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Fig. A2.3. Root growth of HvUGT13248 transgenic Arabidopsis on MS medium 
containing different concentrations of 3,15-diANIV. Lines #42 and #40 were 
transgenic Arabidopsis carrying HvUGT13248 in the ‘Col-0’ background. (D) 
Photos of Arabidopsis seedlings on MS media with 0, 10 or 20 ppm 3,15-diANIV 
at 10 days after germination (DAG). (E) 3,15-diANIV concentration in the shoots 
of Arabidopsis grown on MS media containing 20 ppm 3,15-diANIV at 30 DAG. 
The toxin was not detected in those grown on plain MS media. 
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Fig. A2.4. Root growth of HvUGT13248 transgenic wheat and the non transgenic 
controls on MS medium containing 0 (A) or 10 ppm 3,15-diANIV (B). Lines #8, 
#15 and #37 were transgenic wheat expressing HvUGT13248 in the ‘Bobwhite’ 
(BW) background. 
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Appendix 3: Transgenic barley overexpressing HvUGT13248 show 
enhanced levels of resistance to DON 
In previous chapters, HvUGT13248 was shown to efficiently detoxify DON, 
NIV and several other trichothecene mycotoxins and provide type II resistance to 
FHB when overexpressed in susceptible transgenic wheat. To test the function of 
HvUGT13248 in barley, we created transgenic barley overexpressing 
HvUGT13248 and performed root assay on DON supplemented growth media. 
 
Materials and Methods 
Plant transformation plasmid and barley transformation 
The p6U-HvUGT13248 plasmid, carrying the HvUGT13248 gene driven 
by the maize ubiquitin promoter (Ubi-1), coupled with its first intron (Christensen 
et al. 1992) (Figure A3.1A) was used for Agrobacterium-mediated transformation 
of the barley cultivar ‘Golden Promise’ (GP) by Jochen Kumlehn (IPK, 
Gaterslaben, Germany). A C-terminal FLAG-epitope was fused in frame to the 
HvUGT13248 open reading frame, which enables tracking of the HvUGT13248 
protein with FLAG-epitope antibodies. 
 
Characterization of transgenic barley 
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Western blot analysis using the FLAG-epitope antibodies was conducted 
on the T1 progeny derived from the primary transgenic events. Three transgenic 
events (#39003, #39005 and #39009) accumulating detectable HvUGT13248-
FLAG protein levels were selected and allowed to self-pollinate (Fig. A3.1C). 
Variation in expression levels of the transgene was observed across the selected 
events, with no detectable signal in non transgenic GP control (Fig. A3.1C). 
Southern blot analysis was conducted on T3 individuals to determine if 
they originated from independent transformation events. Genomic DNA was 
digested with the XbaI restriction endonuclease and probed with the full-length 
hygromycin resistance tag gene (HptR). The probe did not hybridize to the GP 
non transgenic controls, while each of the transgenic events exhibited different 
banding patterns, demonstrating that the transgene was successfully integrated 
into these lines and that they originated from independent transformation events 
(Fig. A3.1B). 
 
Results and Discussion 
DON is known to inhibit root elongation in plants (Masuda et al. 2007). 
Therefore, we examined the root growth of HvUGT13248 overexpressing 
transgenic barley seedlings on DON-supplemented growth medium (Fig. A3.2 
and supplementary Fig. SA3.1). T4 seeds of homozygous lineages derived from 
transgenic events #39003, #39005 and #39009 along with the corresponding 
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control, ‘GP’, were germinated on MS medium for 24 hours and subsequently 
transferred to MS medium supplemented with 0, 1, 2 and 5 ppm (mg L-1) DON. 
Root growth was measured once a day from two to seven days after germination 
(DAG). 
In control treatments (0 ppm DON), root growth measurements for the 
transgenic events were not significantly different from non transgenic control (Fig. 
A3.2). However, on plates containing DON, roots of the transgenic events were 
significantly longer than GP (Fig. A3.2 and Fig. SA3.1). Therefore, 
overexpression of HvUGT13248 in barley successfully increased DON 
resistance. 
The enhanced resistance provided by HvUGT13248 overexpression on 
top of the endogenous UGT gene expression shed light on the understanding of 
resistance regulation in plants. Since trichothecenes are toxic to plant cells at 
even low dosages, timing of resistance induction is key to successful disruption 
of disease development. For endogenous UGT gene(s) to function, plants have 
to successfully percept the presence of trichothecenes (maybe also signals of 
Fusarium spp. invasion) before the signal transduction pathways reach to the 
induction of UGT gene expression. The ribosomal inhibition ability of 
trichothecenes makes this process even slower. When a DON detoxification 
gene is constitutively overexpressed, high levels of trichothecene resistance exist 
from the very beginning of disease development, and the later induced UGT 
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expression will reinforce the detoxification effect. Therefore, overexpressing 
HvUGT13248 in natural type II resistant barley plants enhanced the 
trichothecene resistance levels, and we can expect higher trichothecene 
resistance in the transgenic barley in future field trial F. graminearum inoculation 
experiments.  
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Figure A3.1. Transformation plasmid and characterization of transgenic barley. 
(A) The p6U plasmid containing the HvUGT13248 transgene (p6U-
HvUGT13248) was used for barley transformation. Ubi-1 pro., maize ubiquitin-1 
promoter with the first intron; Flg, FLAG-epitope tag. (B) Southern blot analysis 
using 32P-dCTP labeled HptR gene and XbaI digested genomic DNA. (C) 
Western blot analysis using FLAG-epitope antibody. Events #39003, #39005 and 
#39009 were independent transgenic lines in the ‘Golden Promise’ (GP) 
background and GP was the non transgenic control.
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Figure A3.2. Root growth of transgenic barley events (#39003, #39005 and 
#39009) in the ‘Golden Promise’ (GP) background expressing HvUGT13248 on 
MS medium containing 0, 1, 2 and 5 ppm DON. Photos of seedlings are shown in 
Supplementary Fig. SA3.1. 
 
 
 
 
 
 
 
  170 
Supplementary Figure SA3.1. ‘Golden Promise’ (GP) and transgenic barley 
events #39003, #39005 and #39009 expressing HvUGT13248 grown on MS 
medium plates with 0 ppm (upper panel) and 1 ppm DON (lower panel) at 4 days 
after germination (DAG). Scale bars = 5 cm. 
	
